BR-13648B Not for distribution outside of the U.S.
Blood Banking
Centrifugation
Chemistry
Flow Cytometry
Hematology
Hemostasis
Immunoassay
Information Systems
Lab Automation
Molecular Diagnostics
Rapid Diagnostics
AU reagent quick reference guide. Reliable results, enhanced productivity.
AU Chemistry Systems
The precision specifi cations for the AU reagents listed in this document represent the
minimum levels of performance the tests are designed to meet for total precision.
These specifi cations do not represent typical performance, except where indicated.
However, typical performance is signifi cantly better.
The measuring points listed in this document are the photometric time points the software
uses to calculate a result for each assay.
If you require additional information regarding any of the assays, please consult each
individual chemistry’s Instructions for Use (IFU) and analyzer-specifi c setting sheet.
Table of Contents
General ChemistryAlanine Aminotransferase (ALT) ...........................................................4Albumin (ALB) ...........................................................................................4Alkaline Phosphatase (ALP) ..................................................................4Amylase (AMY) .........................................................................................5Aspartate Aminotransferase (AST)......................................................5Bicarbonate (CO2) ..................................................................................5Calcium Arsenazo (CALA) .....................................................................6Calcium oCPC (CA) ................................................................................6Chloride (CL) .............................................................................................6Cholesterol (CHOL) ................................................................................7Creatinine (CRE) ......................................................................................7Creatine Kinase (CK) ..............................................................................7Direct Bilirubin (DBIL) .............................................................................8 Gamma-Glutamyltransferase (GGT)...................................................8 Glucose (GLU) ..........................................................................................9HDL Cholesterol (HDL-C) .....................................................................9Iron (IRON) .................................................................................................9LDL Cholesterol (LDL-C) .................................................................... 10Lactate Dehydrogenase (IFCC) (LDH)............................................ 10Lipase (LIP) ............................................................................................. 10Magnesium (MG) ....................................................................................11Phosphorus, Inorganic (PHOS) .........................................................11Potassium (K) ..........................................................................................11Sodium (NA) ............................................................................................12Total Bilirubin (TBIL) ..............................................................................12Total Protein (TP) ....................................................................................12Triglyceride (TRIG) ................................................................................ 13Unsaturated Iron Binding Capacity (UIBC) .................................... 13Urea Nitrogen (BUN) ............................................................................ 13Uric Acid (UA) .........................................................................................14Urinary/CSF Protein (UCSFP) ............................................................14
Proteins/SerologyAlpha-1-Acidglycoprotein (AAG) ...................................................... 15Alpha-1-Antitrypsin (AAT) ................................................................... 15Anti-Streptolysin O (ASO) .................................................................. 15Apolipoprotein A1 (APO A1) .............................................................. 16Apolipoprotein B (APO B) .................................................................. 16Beta-2 Microglobulin (B2M) ............................................................... 16Ceruloplasmin (CER) ............................................................................17Complement 3 (C3) ...............................................................................17Complement 4 (C4) ...............................................................................17C-Reactive Protein (CRP) .................................................................. 18C-Reactive Protein (CRPN) .............................................................. 18C-Reactive Protein, High Sensitivity (CRPHS) ............................. 18Ferritin (FERR) ....................................................................................... 19Haptoglobin (HAPT) ............................................................................. 19Immunoglobulin A (IGA) ...................................................................... 19Immunoglobulin G (IGG) ..................................................................... 20Immunoglobulin M (IGM) ..................................................................... 20Microalbumin (MALB) .......................................................................... 20Prealbumin (PALB)................................................................................ 21Rheumatoid Factor (RF) ...................................................................... 21Transferrin (TRF) .................................................................................... 21
EsotericsAmmonia (AMMON) ............................................................................. 22Cholinesterase (CHE) .......................................................................... 22Creatine Kinase MB (CKMB) ............................................................. 22Hemoglobin A1c (IFCC) (HBA1C).................................................... 23Lactate (LAC) ......................................................................................... 23Lithium (LI) ............................................................................................... 23
ThyroidsThyroxine (T4) ......................................................................................... 24T-Uptake (TUP) ...................................................................................... 24
Therapeutic Drug Monitoring (TDM)Acetaminophen (ACETA) .................................................................... 25Amikacin (AMIK) .................................................................................... 25Caffeine (CAFF) .................................................................................... 25Carbamazepine (CARB) ...................................................................... 26Digoxin (DIG) .......................................................................................... 26Disopyramide (DISO) ........................................................................... 26Ethosuximide (SUXI) ............................................................................. 27Gentamicin (GENT) .............................................................................. 27Lidocaine (LIDO) ................................................................................... 27Methotrexate (MTRX) ........................................................................... 28N-Acetylprocainamide (NAPA) .......................................................... 28Phenobarbital (PBARB)....................................................................... 28Phenytoin (PHENY) .............................................................................. 29Primidone (PRIM) .................................................................................. 29Procainamide (PROC) ......................................................................... 29Quinidine (QUIN) .................................................................................. 30Salicylic Acid (SALI) ............................................................................. 30Theophylline (THEO) ............................................................................ 30Tobramycin (TOB) ................................................................................. 31Valproic Acid (VPA) .............................................................................. 31Vancomycin (VANC) ............................................................................. 31
Drugs of Abuse Testing (DAT)Amphetamines 300ng (AMPH+) ...................................................... 32Amphetamines 500ng (AMPH+) ...................................................... 32Amphetamines 1000ng (AMPH+) .................................................... 32Amphetamines 300ng SQ (AMPH+) .............................................. 33Amphetamines 500ng SQ (AMPH+)............................................... 33Amphetamines 1000ng SQ (AMPH+) ............................................ 33Barbiturate 200ng (BARB+) .............................................................. 34Barbiturate 300ng (BARB+) .............................................................. 34Barbiturate SQ (BARB+) .................................................................... 34Barbiturate, Tox (TBARB) .................................................................... 35Benzodiazepine 200ng (BENZ+) ...................................................... 35Benzodiazepine 300ng (BENZ+) ...................................................... 35Benzodiazepine SQ (BENZ+) ............................................................ 36Benzodiazepine, Tox (TBENZ) ........................................................... 36Cannabinoid 20ng (THC) ................................................................... 36Cannabinoid 50ng (THC) ................................................................... 37Cannabinoid 100ng (THC) ................................................................. 37Cannabinoid SQ (THC) ....................................................................... 37Cocaine Metabolite 150ng (COCA+) ............................................. 38Cocaine Metabolite 300ng (COCA+) ............................................. 38Cocaine Metabolite SQ (COCA+) ................................................... 38Creatinine, Tox (CRTOX) ..................................................................... 39Ecstasy 300ng (XTC) .......................................................................... 39Ecstasy 500ng (XTC) .......................................................................... 39Ecstasy 300ng SQ (XTC) ................................................................... 40Ecstasy 500ng SQ (XTC) ................................................................... 40Ethyl Alcohol (ETOH+) ........................................................................ 40LSD (LSD) ................................................................................................41LSD SQ (LSD) ........................................................................................41Methadone 150ng (METH+) ...............................................................41Methadone 300ng (METH+) .............................................................. 42Methadone SQ (METH+) .................................................................... 42Methaqualone (METQ+) ...................................................................... 42Methaqualone SQ (METQ+) .............................................................. 43Opiates 300ng (OPIA+) ...................................................................... 43Opiates 2000ng (OPIA+) ................................................................... 43Opiates 300ng SQ (OPIA+) .............................................................. 44Opiates 2000ng SQ (OPIA+)............................................................ 44Oxycodone 100ng (OXY) ................................................................... 44Oxycodone 300ng (OXY) ................................................................... 45Oxycodone SQ (OXY) ......................................................................... 45Phencyclidine (PCP+).......................................................................... 45Phencyclidine SQ (PCP+) .................................................................. 46Propoxyphene (PPX+) .......................................................................... 46Propoxyphene SQ (PPX+) .................................................................. 46Tricyclics, Tox (TRICY) ......................................................................... 47
4
General Chemistry
Chemistry Name Alanine Aminotransferase
(IFCC) Albumin
Alkaline Phosphatase
(IFCC)
Chemistry Abbreviation ALT ALB ALP
Measurement Principle UV/NADH BCG p-Nitro-phenylphosphate
Reaction Type Rate End Rate
Primary Wavelength 340 nm 600 nm 410 nm
Measuring Points 14, 27 0, 1 13, 19 (AU400/AU600/AU640)
16, 27 (AU480/AU680/AU2700/
AU5400)
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 10 μL 2 μL 3 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 5 μL 1.6 μL 1.8 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 7-52 IU/L 0.11-0.87 μkat/L 3.5-5.7 g/dL 35-57 g/L 34-104 IU/L 0.57-1.78 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 3-500 IU/L 0.05-8.33 μkat/L 1.5-6.0 g/dL 15-60 g/L 5-1500 IU/L 0.1-25.0 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 10% CV < 10% CV < 3% CV < 3% CV < 10% CV < 10% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 100 μL, R2 = 50 μL R1 = 58 μL R1 = 60 μL, R2 = 60 μL
AU480/AU680/AU2700/AU5400 R1 = 50 μL, R2 = 25 μL R1 = 46 μL R1 = 36 μL, R2 = 36 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6107 (4 x 500 tests) OSR6102 (4 x 500 tests)
OSR6202 (4 x 910 tests)
OSR6004 (4 x 170 tests)
OSR6104 (4 x 485 tests)
OSR6204 (4 x 840 tests)
AU480/AU680/AU2700/AU5400 OSR6107 (4 x 980 tests)
OSR6607 (4 x 3070 tests)†
OSR6102 (4 x 620 tests)
OSR6202 (4 x 1120 tests)
OSR6602 (4 x 3590 tests)†
OSR6004 (4 x 310 tests)
OSR6104 (4 x 820 tests)
OSR6204 (4 x 1450 tests)
OSR6504 (4 x 2510 tests)†
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 30 days 90 days 14 days
Storage Temperature +2 to +8°C +2 to +25°C +2 to +8°C
Calibration Frequency N/A 30 days N/A
Reagent Blank Frequency 7 days 30 days 14 days
Compatible Anticoagulants Heparin
EDTA1
Heparin
EDTA
Heparin
Calibrator Part Number N/A DR0070-2 N/A
Control Name Bio-Rad*/MAS Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) † AU2700/AU5400 only1 Plasma should be multiplied by 1.02
† AU2700/AU5400 only † AU680/AU2700/AU5400 only
5
General Chemistry
Chemistry Name AmylaseAspartate Aminotransferase
(IFCC)Bicarbonate
Chemistry Abbreviation AMY AST CO2
Measurement Principle CNPG3 UV/NADH Phosphoenolpyruvate Carboxylase
Reaction Type Rate Rate Fixed
Primary Wavelength 410 nm 340 nm 380 nm
Measuring Points 5, 10 14, 27 1, 9
Sample Type Serum/Plasma/Urine Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 10 μL 3 μL
Urine 2 μL N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 5 μL 2.5 μL
Urine 1.6 μL N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 29-103 U/L 0.48-1.72 μkat/L 13-39 U/L 0.22-0.65 μkat/L 21-31 mEq/L 21-31 mmol/L
Urine 5-27 U/hour 0.08-0.45 μkat/L N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 10-2000 U/L 0.2-33.3 μkat/L 3-1000 U/L 0.05-16.7 μkat/L 2-45 mEq/L 2-45 mmol/L
Urine 10-1500 U/L 0.1-25 μkat/L N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 10% CV < 10% CV < 10% CV < 10% CV < 7% CV or SD
< 1.5 mEq/L1
< 7% CV or SD
< 1.5 mmol/L1
Urine < 10% CV < 10% CV N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 200 μL R1 = 50 μL, R2 = 50 μL R1 = 50 μL
AU480/AU680/AU2700/AU5400 R1 = 160 μL R1 = 25 μL, R2 = 25 μL R1 = 42 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6006 (4 x 50 tests)
OSR6106 (4 x 200 tests)
OSR6109 (4 x 500 tests)
OSR6209 (4 x 1000 tests)
OSR6137 (4 x 500 tests)
OSR6237 (4 x 1000 tests)
AU480/AU680/AU2700/AU5400 OSR6006 (4 x 55 tests)
OSR6106 (4 x 240 tests)
OSR6109 (4 x 980 tests)
OSR6209 (4 x 1960 tests)
OSR6509 (4 x 3700 tests)†
OSR6137 (4 x 580 tests)
OSR6237 (4 x 1160 tests)
OSR6537 (4 x 2285 tests)†
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 30 days 30 days 7 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency N/A N/A 1 day
Reagent Blank Frequency 7 days 7 days 1 day
Compatible Anticoagulants Heparin Heparin Heparin
Calibrator Part Number N/A N/A DR0070 (1&2)
Control Name Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) † AU680/AU2700/AU5400 only 1 Use the greater number
† AU680/AU2700/AU5400 only
6
General Chemistry
Chemistry Name Calcium Arsenazo Calcium oCPC Chloride
Chemistry Abbreviation CALA CA CL
Measurement Principle Arsenazo o-Cresolphthalein Complexone ISE - Oriented PVC Membrane
Reaction Type End End N/A
Primary Wavelength 660 nm 570 nm N/A
Measuring Points 0, 10 0, 27/0, 10 N/A
Sample Type Serum/Plasma/Urine Serum/Urine Serum/Plasma/Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3.5 μL 5 μL 20 μL
Urine 2 μL 2 μL 25 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2.5 μL 3.7 μL 20 μL
Urine 2 μL 3 μL 20 μL
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 8.6-10.3 mg/dL 2.1-2.6 mmol/L 8.6-10.2 mg/dL 2.1-2.6 mmol/L 98-107 mEq/L 98-107 mmol/L
Urine 100-300 mg/24
hrs
25-75 mmol/24
hrs
100-300 mg/24
hrs
25-75 mmol/24
hrs
110-250 mEq/24
hrs
110-250 mmol/24
hrs
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 4-18 mg/dL 1-4.5 mmol/L 0-18 mg/dL 0-4.5 mmol/L 50-200 mEq/L 50-200 mmol/L
Urine 0.1-40.0 mg/dL 0.025-10 mmol/L 0-40 mg/dL 0-10 mmol/L 15-400 mEq/L 15-400 mmol/L
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV < 5% CV < 5% CV or SD
< 0.33 mg/dL1
< 5% CV or SD
< 0.08 mmol/L1
< 5% CV < 5% CV
Urine < 5% CV or SD
< 0.33 mg/dL1
< 5% CV or SD
< 0.08 mmol/L1
< 5% CV < 5% CV
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 Serum: R1 = 29 μL
Urine: R1 = 25 μL
R1 = 60 μL, R2 = 60 μL N/A
AU480/AU680/AU2700/AU5400 Serum: R1 = 21 μL
Urine: R1 = 25 μL
Serum: R1 = 45 μL, R2 = 45 μL
Urine: R1 = 60 μL, R2 = 60 μL
N/A
Cartridge Part Number/Size
AU400/AU600/AU640 OSR60117 (4 x 500 tests)
OSR61117 (4 x 930 tests)
OSR6113 (4 x 450 tests)
OSR6213 (4 x 815 tests)
MU9196 (40000 tests/electrode)
AU480/AU680/AU2700/AU5400 OSR60117 (4 x 700 tests)
OSR61117 (4 x 1300 tests)
OSR65117 (4 x 4500 tests)†
OSR6113 (4 x 590 tests)
OSR6213 (4 x 1080 tests)
MU9196 (40000 tests/electrode)
Liquid or Lyophilized Liquid Liquid N/A
On-Instrument Stability 90 days 30 days 6 months (electrode)
90 days (reagents)
Storage Temperature +2 to +8°C +2 to +25°C +2 to +25°C
Calibration Frequency 30 days 1 day 1 day
Reagent Black Frequency 30 days 1 day N/A
Compatible Anticoagulants Heparin N/A Lithium Heparin
Ammonium Heparin
Calibrator Part Number Serum/Plasma: DR0070 (1&2)
Urine: DR0090
Serum/Plasma: DR0070 (1&2)
Urine: DR0090
Serum Low and High Standards:
AUH1014, AUH1015
Urine Low and High Standards:
AUH1016
Control Name Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Control Part Number N/A N/A N/A
Comment(s) † AU680/AU2700/AU5400 only 1 Use the greater number Reagents: AUH1011 Buffer
AUH1012 Mid-Standard
AUH1013 Reference
7
General Chemistry
Chemistry Name Cholesterol Creatinine Creatine Kinase
Chemistry Abbreviation CHOL CRE CK
Measurement Principle Enzymatic Modified Jaffe, Kinetic IFCC-CK (NAC)
Reaction Type End Fixed Rate
Primary Wavelength 540 nm 520 nm 340 nm
Measuring Points 0, 27 13, 24 21, 27
Sample Type Serum/Plasma Serum/Plasma/Urine Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3 μL 20 μL 3 μL
Urine N/A 8 μL N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 8 μL 2.5 μL
Urine N/A 8 μL N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma < 200 mg/dL < 5.18 mmol/L M: 0.7-1.3 mg/dL
F: 0.6-1.2 mg/dL
M: 62-115
μmol/L
F: 53-106 μmol/L
30-223 U/L 0.50-3.72 μkat/L
Urine N/A N/A M: 14-26 mg/
kg/24 hrs
F: 11-20 mg/
kg/24 hrs
N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 25-700 mg/dL 0.6-18.1 mmol/L 0.2-25.0 mg/dL 18-2210 μmol/L 10-2000 U/L 0.17-33.3 μkat/L
Urine N/A N/A 1-300 mg/dL 88-26520 μmol/L N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 3% CV < 3% CV < 6% CV < 6% CV < 10% CV < 10% CV
Urine N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 45 μL R1 = 120 μL, R2 = 120 μL R1 = 120 μL, R2 = 30 μL
AU480/AU680/AU2700/AU5400 R1 = 24 μL Serum: R1 = 48 μL, R2 = 48 μL
Urine: R1 = 120 μL, R2 = 120 μL
R1 = 100 μL, R2 = 25 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6116 (4 x 500 tests)
OSR6216 (4 x 1000 tests)
OSR6178 (4 x 420 tests) OSR6179 (4 x 200 tests)
OSR6279 (4 x 425 tests)
AU480/AU680/AU2700/AU5400 OSR6116 (4 x 910 tests)
OSR6216 (4 x 1830 tests)
OSR6516 (4 x 3975 tests)†
OSR6178 (4 x 990 tests)
OSR6678 (4 x 3070 tests)†
OSR6179 (4 x 230 tests)
OSR6279 (4 x 490 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 7 days 30 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 30 days 1 day N/A
Reagent Blank Frequency 30 days 1 day 30 days
Compatible Anticoagulants EDTA
Heparin
Heparin Heparin
Calibrator Part Number DR0070-2 Serum/Plasma: DR0070 (1&2)
Urine: DR0091
N/A
Control Name Bio-Rad*/MAS Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) † AU680/AU2700/AU5400 only † AU2700/AU5400 only
8
General Chemistry
Chemistry Name Direct Bilirubin Direct Bilirubin Gamma-Glutamyltransferase
Chemistry Abbreviation DBIL1 DBIL GGT
Measurement Principle Diazonium Salt, DPD Diazonium Salt, DPD Glutamyl-carboxy-p-nitroanilide
Reaction Type End End Rate
Primary Wavelength 570 nm 540 nm 410 nm
Measuring Points 0, 2 0, 12/0, 10 14, 23 (AU400/AU600/AU640)
16, 23 (AU480/AU680/AU2700/
AU5400)
Sample Type Serum/Plasma Serum Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3 μL 6 μL 6 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2.5 μL 5 μL 4 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 0.03-0.18 mg/dL 0.51-3.08 μmol/L 0.0-0.2 mg/dL 0-3.42 μmol/L 9-64 U/L 0.15-1.07 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 0-10 mg/dL 0-171 μmol/L 0.05-10 mg/dL 0.9-171 μmol/L 3-1200 U/L 0.05-20 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV or SD
≤ 0.07 mg/dL2
< 5% CV or SD
≤ 1.2 μmol/L2
< 8% CV or SD
≤ 0.21 mg/dL1
< 8% CV or SD
≤ 3.6 μmol/L1
< 10% CV < 10% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 30 μL R1 = 150 μL, R2 = 30 μL R1 = 75 μL, R2 = 75 μL
AU480/AU680/AU2700/AU5400 R1 = 25 μL R1 = 125 μL, R2 = 25 μL R1 = 50 μL, R2 = 50 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6111 (4 x 200 tests)
OSR6211 (4 x 660 tests)
OSR61181 (4 x 300 tests) OSR6119 (4 x 200 tests)
OSR6219 (4 x 660 tests)
AU480/AU680/AU2700/AU5400 OSR6111 (4 x 200 tests)
OSR6211 (4 x 660 tests)
OSR6511 (4 x 3835 tests)†
OSR61181 (4 x 360 tests) OSR6119 (4 x 310 tests)
OSR6219 (4 x 980 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 21 days 30 days 30 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 7 days 21 days N/A
Reagent Blank Frequency 7 days 21 days 30 days
Compatible Anticoagulants Heparin Heparin EDTA
Calibrator Part Number DR0070-1 DR0070-1 N/A
Control Name Bio-Rad*/MAS Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) 1 Both a color test DBIL-C and blank
test DBIL-B need to be run2 Use the greater number
† AU680/AU2700/AU5400 only
1 Use the greater number
9
General Chemistry
Chemistry Name Glucose HDL Cholesterol Iron
Chemistry Abbreviation GLU HDL-C IRON
Measurement Principle Hexokinase-UV/NAD Accelerator Selective Detergent TPTZ
Reaction Type End End End
Primary Wavelength 340 nm 600 nm 600 nm
Measuring Points 0, 27/0, 10 0, 27/0, 10 0, 12/0, 10
Sample Type Serum/Plasma/Urine/CSF Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 2 μL 20 μL
Urine 3 μL N/A N/A
CSF 2 μL N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 2 μL 12 μL
Urine 3 μL N/A N/A
CSF 1.6 μL N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 70-105 mg/dL 3.9-5.8 mmol/L 23-92 mg/dL 0.59-2.38 mmol/L 50-212 μg/dL 8.9-37.9 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF 40-70 mg/dL 2.2-3.9 mmol/L N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 10-800 mg/dL 0.6-44.4 mmol/L 2.5-200 mg/dL 0.07-5.17 mmol/L 10-1000 μg/dL 1.8-178.6 μmol/L
Urine 10-700 mg/dL 0.6-39 mmol/L N/A N/A N/A N/A
CSF 10-800 mg/dL 0.6-44.4 mmol/L N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 3% CV < 3% CV < 5% CV < 5% CV < 5% CV < 5% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 50 μL, R2 = 25 μL R1 = 200 μL, R2 = 66 μL R1 = 50 μL, R2 = 50 μL
AU480/AU680/AU2700/AU5400 Serum: R1 = 40 μL, R2 = 20 μL
Urine: R1 = 50 μL, R2 = 25 μL
R1 = 200 μL, R2 = 66 μL R1 = 30 μL, R2 = 30 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6121 (4 x 500 tests)
OSR6221 (4 x 1035 tests)
OSR6195 (4 x 150 tests)
OSR6295 (4 x 250 tests)
OSR6186 (4 x 300 tests)
OSR6286 (4 x 595 tests)
AU480/AU680/AU2700/AU5400 OSR6121 (4 x 610 tests)
OSR6221 (4 x 1300 tests)
OSR6621 (4 x 3755 tests)†
OSR6195 (4 x 150 tests)
OSR6295 (4 x 250 tests)
OSR6186 (4 x 500 tests)
OSR6286 (4 x 970 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 30 days 30 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 30 days 7 days 30 days
Reagent Blank Frequency 30 days 7 days 30 days
Compatible Anticoagulants EDTA
Heparin
Sodium Fluoride
EDTA
Heparin
Heparin
Calibrator Part Number Serum/Plasma: DR0070-2
Urine: DR0090
ODC0023 DR0070-1
Control Name Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) † AU2700/AU5400 only
10
General Chemistry
Chemistry Name LDL CholesterolLactate Dehydrogenase
(IFCC)Lipase
Chemistry Abbreviation LDL-C LDH LIP
Measurement Principle Liquid Selective Detergent Lactate-Pyruvate (NAD); IFCC Enzymatic, Colorimetric
Reaction Type End Rate Rate
Primary Wavelength 540 nm 340 nm 540 nm
Measuring Points 0, 27/0, 10 14, 21 (AU400/AU640)
15, 23 (AU480/AU680/AU2700/
AU5400)
17, 27
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 3 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2 μL 2.3 μL 1.6 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 75-193 mg/dL 1.9-5.0 mmol/L 140-271 U/L 2.3-4.5 μkat/L 11-82 U/L 0.18-1.37 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 7.0-400 mg/dL 0.2-10.3 mmol/L 25-1200 U/L 0.4-20.0 μkat/L 3-600 U/L 0.05-10 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV < 5% CV < 10% CV < 10% CV < 10% CV < 10% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 200 μL, R2 = 66 μL R1 = 80 μL, R2 = 40 μL R1 = 180 μL, R2 = 60 μL
AU480/AU680/AU2700/AU5400 R1 = 200 μL, R2 = 66 μL R1 = 62 μL, R2 = 31 μL R1 = 144 μL, R2 = 48 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6196 (4 x 150 tests)
OSR6296 (4 x 250 tests)
OSR6127 (4 x 500 tests)
OSR6227 (4 x 625 tests)
OSR6130 (4 x 45 tests)
OSR6230 (4 x 150 tests)
AU480/AU680/AU2700/AU5400 OSR6196 (4 x 150 tests)
OSR6296 (4 x 250 tests)
OSR6127 (4 x 640 tests)
OSR6227 (4 x 800 tests)
OSR6130 (4 x 45 tests)
OSR6230 (4 x 180 tests)
Liquid or Lyophilized Liquid Liquid Lyophilized
On-Instrument Stability 30 days 30 days 21 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 7 days N/A 7 days
Reagent Blank Frequency 7 days 30 days 7 days
Compatible Anticoagulants EDTA
Heparin
Heparin Heparin
Calibrator Part Number ODC0024 N/A Included
Control Name Bio-Rad*/MAS Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s)
11
General Chemistry
Chemistry Name MagnesiumPhosphorus
(Inorganic)Potassium
Chemistry Abbreviation MG PHOS K
Measurement Principle Xylidyl Blue Phosphomolybdate Complex ISE - Crown-Ether Membrane
Reaction Type End End N/A
Primary Wavelength 520 nm 340 nm N/A
Measuring Points 0, 27 (AU400/AU600/AU640)
0, 10 (AU480/AU680/AU2700/AU5400)
0, 27/0, 10 N/A
Sample Type Serum/Plasma/Urine Serum/Urine Serum/Plasma/Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 3 μL 20 μL
Urine 2 μL 3 μL of a 1/10 20 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 2.5 μL 25 μL
Urine 2 μL 3 μL of a 1/10 20 μL
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 1.9-2.7 mg/dL 0.78-1.11 mmol/L 3.7-7.2 mg/dL 1.2-2.3 mmol/L 3.5-5.1 mEq/L 3.5-5.1 mmol/L
Urine 24-255 mg/24 hrs 2-21.2 mEq/24 hrs 0.3-1.3 g/24 hrs 9.7-42 mmol/24 hrs 25-125 mEq/
24 hrs
25-125 mmol/
24 hrs
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 0.5-8.0 mg/dL 0.2-3.3 mmol/L 1-20 mg/dL 0.3-6.5 mmol/L 1-10 mEq/L 1-10 mmol/L
Urine 0.5-10.0 mg/dL 0.2-4.1 mmol/L 10-200 mg/dL 3.2-64.5 mmol/L 2-200 mEq/L 2-200 mmol/L
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV < 5% CV < 5% CV < 5% CV < 5% CV < 5% CV
Urine N/A N/A < 5% CV < 5% CV
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 200 μL R1 = 30 μL, R2 = 30 μL N/A
AU480/AU680/AU2700/AU5400 Serum: R1 = 160 μL
Urine: R1 = 200 μL
Serum: R1 = 25 μL, R2 = 25 μL
Urine: R1 = 30 μL, R2 = 30 μL
N/A
Cartridge/Kit Size
AU400/AU600/AU640 OSR6189 (4 x 200 tests) OSR6122 (4 x 500 tests)
OSR6222 (4 x 1330 tests)
MU9195 (40000 tests/electrode)
AU480/AU680/AU2700/AU5400 OSR6189 (4 x 250 tests) OSR6122 (4 x 590 tests)
OSR6222 (4 x 1570 tests)
MU9195 (40000 tests/electrode)
Liquid or Lyophilized Liquid Liquid N/A
On-Instrument Stability 7 days 30 days 6 months (electrode)
90 days (reagents)
Storage Temperature +2 to +8°C +2 to +8°C +2 to +25°C
Calibration Frequency 7 days 30 days 1 day
Reagent Blank Frequency 1 day 30 days N/A
Compatible Anticoagulants Heparin N/A Lithium Heparin
Ammonium Heparin
Calibrator Part Number Serum/Plasma: DR0070-2
Urine: DR0090
Serum/Plasma: DR0070-2
Urine: DR0090
Serum Low and High Standards:
AUH1014, AUH1015
Urine Low and High Standards:
AUH1016
Control Name Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) Reagents: AUH1011 Buffer
AUH1012 Mid-Standard
AUH1013 Reference
12
General Chemistry
Chemistry Name Sodium Total Bilirubin Total Protein
Chemistry Abbreviation NA TBIL1 TP
Measurement Principle ISE - Crown-Ether Membrane Diazonium Salt, DPD Biuret; Blanked
Reaction Type N/A End End
Primary Wavelength N/A 570 nm 540 nm
Measuring Points N/A 0, 10 0, 27/0, 10
Sample Type Serum/Plasma/Urine Serum/Plasma Serum
Sample Size (AU400/AU600/AU640)
Serum/Plasma 20 μL 6 μL 3.0 μL (AU400)/6.0 μL
Urine 20 μL N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 25 μL 5 μL 5 μL
Urine 20 μL N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 136-145 mEq/L 136-145 mmol/L 0.3-1.0 mg/dL 5.1-17.1 μmol/L 6.4-8.9 g/dL 64-89 g/L
Urine 40-220 mEq/24
hrs
40-220 mmol/24
hrs
N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 50-200 mEq/L 50-200 mmol/L 0-30 mg/dL 0-513 μmol/L 3-12 g/dL 30-120 g/L
Urine 10-400 mEq/L 10-400 mmol/L N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV < 5% CV < 5% CV or SD
≤ 0.10 mg/dL2
< 5% CV or SD
≤ 1.7 μmol/L2
< 4% CV < 4% CV
Urine < 5% CV < 5% CV N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 N/A R1 = 30 μL R1 = 50 μL, R2 = 50 μL
AU480/AU680/AU2700/AU5400 N/A R1 = 26 μL R1 = 33 μL, R2 = 33 μL
Cartridge Part Number/Size
AU400/AU600/AU640 MU9194 (40000 tests/electrode) OSR6112 (4 x 500 tests)
OSR6212 (4 x 1300 tests)
OSR6132 (4 x 500 tests)
OSR6232 (4 x 960 tests)
AU480/AU680/AU2700/AU5400 MU9194 (40000 tests/electrode) OSR6112 (4 x 590 tests)
OSR6212 (4 x 1570 tests)
OSR6512 (4 x 3465 tests)†
OSR6132 (4 x 750 tests)
OSR6232 (4 x 1440 tests)
OSR6632 (4 x 4255 tests)†
Liquid or Lyophilized N/A Liquid Liquid
On-Instrument Stability 6 months (electrode)
90 days (reagents)
90 days 30 days
Storage Temperature +2 to +25°C +2 to +8°C +2 to +25°C
Calibration Frequency 1 day 30 days As needed
Reagent Blank Frequency N/A 30 days As needed
Compatible Anticoagulants Lithium Heparin
Ammonium Heparin
EDTA
Heparin
Heparin
Calibrator Part Number Serum Low and High Standards:
AUH1014, AUH1015
Urine Low and High Standards:
AUH1016
DR0070-1 DR0070-2
Control Name Bio-Rad*/MAS Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) Reagents: AUH1011 Buffer
AUH1012 Mid-Standard
AUH1013 Reference
1 Both a color test TBIL-C and blank test
TBIL-B need to be run2 Use the greater number
† AU680/AU2700/AU5400 only
† AU2700/AU5400 only
13
General Chemistry
Chemistry Name Triglyceride Unsaturated Iron Binding Capacity Urea Nitrogen
Chemistry Abbreviation TRIG UIBC BUN
Measurement Principle Glycerol Phosphate Oxidase Nitroso-PSAP Urease GLDH
Reaction Type End End Rate
Primary Wavelength 660 nm 800 nm 340 nm
Measuring Points 0, 27/0, 10 0, 27/0, 10 12, 18
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma/Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 10 μL 2.5 μL
Urine N/A N/A 3 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 8 μL 2 μL
Urine N/A N/A 2 μL
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma < 150 mg/dL < 1.7 mmol/L 155-355 μg/dL 27.7-63.4 μmol/L 7-25 mg/dL 2.5-8.9 mmol/L
Urine N/A N/A N/A N/A 7-16 g/24 hrs 250-571 mmol/24
hrs
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 10-1000 mg/dL 0.1-11.3 mmol/L 55-450 μg/dL 9.8-80.4 μmol/L 2-130 mg/dL 0.7-46.4 mmol/L
Urine N/A N/A N/A N/A 20-1300 mg/dL 7-464 mmol/L
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV < 5% CV < 10% CV < 10% CV < 5% CV < 5% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 120 μL, R2 = 25 μL R1 = 150 μL, R2 = 30 μL1 R1 = 50 μL, R2 = 50 μL
AU480/AU680/AU2700/AU5400 R1 = 66 μL, R2 = 17 μL R1 = 120 μL, R2 = 24 μL1 R1 = 40 μL, R2 = 40 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR60118 (4 x 200 tests)
OSR61118 (4 x 500 tests)
OSR61205 (4 x 200 tests) OSR6134 (4 x 500 tests)
OSR6234 (4 x 935 tests)
AU480/AU680/AU2700/AU5400 OSR60118 (4 x 290 tests)
OSR61118 (4 x 735 tests)
OSR66118 (4 x 2530 tests)†
OSR61205 (4 x 240 tests) OSR6134 (4 x 620 tests)
OSR6234 (4 x 1230 tests)
OSR6634 (4 x 4115 tests)†
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 30 days 30 days 30 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 30 days 14 days 14 days
Reagent Blank Frequency 30 days 14 days 14 days
Compatible Anticoagulants EDTA
Heparin
Heparin EDTA
Lithium Heparin
Sodium Heparin
Calibrator Part Number DR0070-2 DR0070-2 Serum/Plasma: DR0070-2
Urine: DR0090
Control Name Bio-Rad*/MAS Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A N/A
Comment(s) † AU2700/AU5400 only 1 Transfer R1a into R1 and R2a into R2 † AU2700/AU5400 only
14
General Chemistry
Chemistry Name Uric Acid Urinary/CSF Protein
Chemistry Abbreviation UA UCSFP
Measurement Principle Uricase Pyrogallol Red
Reaction Type End End
Primary Wavelength 660 nm 600 nm
Measuring Points 0, 27/0, 10 0, 10
Sample Type Serum/Plasma/Urine Urine/CSF
Sample Size (AU400/AU600/AU640)
Serum/Plasma 7 μL N/A
Urine 2 μL 2 μL
CSF N/A 2 μL
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 5.6 μL N/A
Urine 1.6 μL 1.6 μL
CSF N/A 1.6 μL
Reference Interval SI Units SI Units
Serum/Plasma 2.3-7.6 mg/dL 137-452 μmol/L N/A N/A
Urine 250-800 mg/24
hrs
1488-4760
μmol/24 hrs
50-80 mg/24 hrs
at rest
0.05-0.8 g/24 hrs
at rest
CSF N/A N/A Adults: 15-45
mg/dL
Newborns < 1
month: 15-130
mg/dL
Adults: 0.15-0.45
g/L
Newborns < 1
month: 0.15-1.30
g/L
Analytical Range SI Units SI Units
Serum/Plasma 1.5-30 mg/dL 89-1785 μmol/L N/A N/A
Urine 1-100 mg/dL 60-5950 μmol/24
hrs
4-200mg/dL 0.04-2 g/L
CSF N/A N/A 4-200mg/dL 0.04-2 g/L
Precision Specification SI Units SI Units
Serum/Plasma < 3% CV < 3% CV N/A N/A
Urine < 5% CV < 5% CV < 5% CV < 5% CV
CSF N/A N/A < 5% CV < 5% CV
Reagent Volume
AU400/AU600/AU640 R1 = 60 μL, R2 = 25 μL R1 = 190 μL
AU480/AU680/AU2700/AU5400 R1 = 48 μL, R2 = 20 μL R1 = 152 μL
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6098 (4 x 200 tests)
OSR6198 (4 x 500 tests)
OSR6298 (4 x 700 tests)
OSR6170 (4 x 100 tests)
OSR6270 (4 x 270 tests)
AU480/AU680/AU2700/AU5400 OSR6098 (4 x 250 tests)
OSR6198 (4 x 625 tests)
OSR6298 (4 x 880 tests)
OSR6698 (4 x 2265 tests)†
OSR6170 (4 x 125 tests)
OSR6270 (4 x 330 tests)
Liquid or Lyophilized Liquid Liquid
On-Instrument Stability 30 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C
Calibration Frequency 30 days 90 days
Reagent Blank Frequency 30 days 90 days
Compatible Anticoagulants Heparin N/A
Calibrator Part Number Serum/Plasma: DR0070-2
Urine: DR0090
Urine: DR0090 only
Urine/CSF: Included in kit
Control Name Serum/Plasma: Bio-Rad*/MAS
Urine: No specific recommendation
No specific recommendation
Control Part Number N/A N/A
Comment(s) † AU2700/AU5400 only
15
Proteins/Serology
Chemistry Name Alpha-1-Acidglycoprotein Alpha-1-Antitrypsin Anti-Streptolysin O
Chemistry Abbreviation AAG AAT ASO
Measurement Principle Immunoturbidimetric Immunoturbidimetric Latex Particle Immunoturbidimetric
Reaction Type End End Fixed
Primary Wavelength 660 nm 600 nm 600 nm
Measuring Points 0, 27/0, 10 0, 27/0, 10 12, 16
Sample Type Serum Serum Serum
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 2 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 1.6 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 44-113 mg/dL 0.44-1.13 g/L 84-218 mg/dL 0.84-2.18 g/L 0-250 IU/mL 0-250 IU/mL
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 20-200 mg/dL 0.2-2 g/L 30-500 mg/dL 0.3-5 g/L 100-1000 IU/mL 100-1000 IU/mL
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 10% CV < 10% CV < 10% CV < 10% CV < 10% CV < 10% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 200 μL, R2 = 45 μL R1 = 200 μL, R2 = 65 μL R1 = 182 μL, R2 = 25 μL1
AU480/AU680/AU2700/AU5400 R1 = 160 μL, R2 = 36 μL R1 = 160 μL, R2 = 52 μL R1 = 182 μL, R2 = 25 μL1
Cartridge/Kit Size
AU400/AU640 OSR6162 (4 x 100 tests) OSR6163 (4 x 100 tests) OSR6194 (4 x 280 tests)
AU480/AU680/AU2700/AU5400 OSR6162 (4 x 120 tests) OSR6163 (4 x 120 tests) OSR6194 (4 x 280 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 90 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 90 days 7 days
Reagent Blank Frequency 14 days 90 days 7 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number ODR3023 ODR3023 ODR3021
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) 1 Gently invert R2 5-10 times before
placing on instrument and weekly
16
Proteins/Serology
Chemistry Name Apolipoprotein A1 Apolipoprotein B Beta-2 Microglobulin
Chemistry Abbreviation APO A1 APO B B2M
Measurement Principle Immunoturbidimetric Immunoturbidimetric Immunoturbidimetric
Reaction Type End End Fixed
Primary Wavelength 540 nm 340 nm 570 nm
Measuring Points 0, 27/0, 10 0, 27/0, 10 12, 21
Sample Type Serum Serum Serum
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 2 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 1.6 μL 1.6 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 100-200 mg/dL 1-2 g/L 50-155 mg/dL 0.5-1.6 g/L 0.097-0.184 mg/dL 0.00097-0.00184
g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 40-250 mg/dL 0.4-2.5 g/L 40-200 mg/dL 0.4-2.0 g/L 0.05-1.6 mg/dL 0.0005-0.016 g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 10% CV < 10% CV < 10% CV < 10% CV < 10% CV < 10% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 65 μL, R2 = 65 μL R1 = 65 μL, R2 = 35 μL R1 = 100 μL, R2 = 80 μL
AU480/AU680/AU2700/AU5400 R1 = 52 μL, R2 = 52 μL R1 = 52 μL, R2 = 28 μL R1 = 80 μL, R2 = 62 μL
Cartridge/Kit Size
AU400/AU600/AU640 OSR6142 (4 x 200 tests) OSR6143 (4 x 200 tests) OSR6151 (4 x 100 tests)
AU480/AU680/AU2700/AU5400 OSR6142 (4 x 250 tests) OSR6143 (4 x 250 tests) OSR6151 (4 x 130 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 90 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 90 days 7 days 90 days
Reagent Blank Frequency 90 days 7 days 90 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number ODR3022 ODR3022 ODR3023
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s)
17
Proteins/Serology
Chemistry Name Ceruloplasmin Complement 3 Complement 4
Chemistry Abbreviation CER C3 C4
Measurement Principle Immunoturbidimetric Immunoturbidimetric Immunoturbidimetric
Reaction Type End End End
Primary Wavelength 340 nm 380 nm 340 nm
Measuring Points 0, 27/0, 10 0, 27/0, 10 0, 27/0, 10
Sample Type Serum/Plasma Serum Serum
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 2 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2 μL 1.6 μL 1.6 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 180-580 mg/L 18-58 mg/dL 87-200 mg/dL 0.87-2.0 g/L 19-52 mg/dL 0.19-0.52 g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 60-2000 mg/L 6-200 mg/dL 15-500 mg/dL 0.15-5.0 g/L 8-150 mg/dL 0.08-1.5 g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 10% CV < 10% CV < 5% CV < 5% CV < 5% CV < 5% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 180 μL, R2 = 50 μL R1 = 50 μL, R2 = 40 μL R1 = 50 μL, R2 = 40 μL
AU480/AU680/AU2700/AU5400 R1 = 180 μL, R2 = 50 μL R1 = 40 μL, R2 = 32 μL R1 = 40 μL, R2 = 32 μL
Cartridge/Kit Size
AU400/AU600/AU640 OSR6164 (4 x 100 tests) OSR6159 (4 x 200 tests) OSR6160 (4 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR6164 (4 x 125 tests) OSR6159 (4 x 260 tests) OSR6160 (4 x 260 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 90 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 90 days 90 days
Reagent Blank Frequency 14 days 90 days 90 days
Compatible Anticoagulants Heparin N/A N/A
Calibrator Part Number ODR3023 ODR3021 ODR3021
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s)
18
Proteins/Serology
Chemistry Name C-Reactive Protein C-Reactive Protein C-Reactive Protein, High Sensitivity
Chemistry Abbreviation CRP CRPN CRPHS
Measurement Principle Immunoturbidimetric Latex Particle Immunoturbidimetric Latex Particle Immunoturbidimetric
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 570 nm 570 nm
Measuring Points 11, 27 12, 22 12, 22
Sample Type Serum Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 18 μL 2.0 μL 3.0 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma AU480/680: 18 μL
AU2700/AU5400: 15 μL
1.6 μL AU480/680: 3.0 μL
AU2700/AU5400: 3.5 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma < 5 mg/L < 0.5 mg/dL < 10 mg/L < 1 mg/dL < 10 mg/L < 1 mg/dL
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 5-300 mg/L 0.5-30 mg/dL 1-480 mg/L 0.1-48 mg/dL 0.2-160 mg/L 0.02-16 mg/dL
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV or SD
≤ 1 mg/L1
< 5% CV or SD
≤ 0.1 mg/dL1
≤10% CV or SD
≤ 0.25 mg/L1
≤ 10% CV or SD
≤ 0.025 mg/dL1
< 10% CV or SD
≤ 0.02 mg/L1
≤ 10% CV or SD
≤ 0.002 mg/dL1
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 70 μL, R2 = 30 μL R1 = 150 μL, R2 = 150 μL2 R1 = 75 μL, R2 = 75 μL
AU480/AU680/AU2700/AU5400 AU480/AU680: R1 = 70 μL, R2 = 30 μL
AU2700/AU5400: R1 = 47 μL, R2 = 20 μL
R1 = 120 μL, R2 = 120 μL2 R1 = 75 μL, R2 = 75 μL
Cartridge/Kit Size
AU400/AU600/AU640 OSR6147 (4 x 200 tests) OSR6199 (4 x 190 tests) OSR6199 (4 x 360 tests)
AU480/AU680/AU2700/AU5400 OSR6147
AU480/AU680 (4 x 200 tests)
AU2700/AU5400 (4 x 300 tests)
OSR6199 (4 x 230 tests) OSR6199 (4 x 380 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 90 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 90 days 90 days 90 days
Reagent Blank Frequency 90 days 90 days 90 days
Compatible Anticoagulants N/A EDTA
Lithium Heparin
EDTA
Lithium Heparin
Calibrator Part Number ODR3021 ODC0026 ODC0027
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) 1 Use the greater number 1 Use the greater number2 Gently invert R2 5-10 times before
placing on instrument and weekly
1 Use the greater number
19
Proteins/Serology
Chemistry Name Ferritin Haptoglobin Immunoglobulin A
Chemistry Abbreviation FERR HAPT IGA
Measurement Principle Latex Particle Immunoturbidimetric Immunoturbidimetric Immunoturbidimetric
Reaction Type Fixed End End
Primary Wavelength 600 nm 600 nm 600 nm
Measuring Points 12, 18 0 , 27/0, 10 0, 27/0, 10
Sample Type Serum Serum Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 18 μL 2 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 18 μL 1.6 μL 1.6 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 12-200 ng/mL 12-200 μg/L 44-215 mg/dL 0.44-2.15 g/L 66-433 mg/dL 0.66-4.33 g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 8-450 ng/mL 8-450 μg/L 30-400 mg/dL 0.3-4.0 g/L 10-700 mg/dL 0.1-7.0 g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 8% CV < 8% CV < 10% CV < 10% CV < 8% CV < 8% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 120 μL, R2 = 25 μL1 R1 = 165 μL, R2 = 45 μL R1 = 70 μL, R2 = 55 μL
AU480/AU680/AU2700/AU5400 R1 = 120 μL, R2 = 25 μL1 R1 = 182 μL, R2 = 25 μL R1 = 56 μL, R2 = 44 μL
Cartridge/Kit Size
AU400/AU600/AU640 OSR61203 (4 x 200 tests) OSR6165 (4 x 100 tests) OSR61171 (4 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR61203 (4 x 200 tests) OSR6165 (4 x 135 tests) OSR61171 (4 x 250 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 30 days 90 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 90 days 90 days
Reagent Blank Frequency 14 days 90 days 90 days
Compatible Anticoagulants N/A N/A EDTA
Lithium Heparin
Calibrator Part Number ODR3021 ODR3023 ODR3021
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) 1 Gently invert R2 5-10 times before
placing on instrument and weekly
20
Proteins/Serology
Chemistry Name Immunoglobulin G Immunoglobulin M Microalbumin
Chemistry Abbreviation IGG IGM MALB
Measurement Principle Immunoturbidimetric Immunoturbidimetric Immunoturbidimetric
Reaction Type End End End
Primary Wavelength Serum/Plasma: 600 nm
CSF: 340 nm
340 nm 340 nm
Measuring Points 0, 23/0, 10 0, 27/0, 10 0, 27/0, 10
Sample Type Serum/Plasma/CSF Serum/Plasma Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 2 μL N/A
Urine N/A N/A 5 μL
CSF 10 μL N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 1.6 μL 1.6 μL N/A
Urine N/A N/A 4 μL
CSF 10 μL N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 635-1741 mg/dL 6.35-17.41 g/L 45-281 mg/dL 0.45-2.81 g/L N/A N/A
Urine N/A N/A N/A N/A < 30 mg/24 hrs < 0.03 g/24 hrs
CSF 15–20 y:
3.5 mg/dL ± 2.0
mg/dL
21– 40 y:
4.2 mg/dL ± 1.4
mg/dL
41– 60 y:
4.7 mg/dL ± 1.0
mg/dL
15–20 y:
0.035 g/L ± 0.02
g/L
21– 40 y:
0.042 g/L ± 0.014
g/L
41– 60 y:
0.047 g/L ± 0.01
g/L
N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 75-3000 mg/dL 0.75-30 g/L 20-500 mg/dL 0.2-5.0 g/L N/A N/A
Urine N/A N/A N/A N/A 0.5-30 mg/dL 0.005-0.30 g/L
CSF 2-50 mg/dL 0.02-0.50 g/L N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 7.5% CV or SD
< 0.5 mg/dL1
< 7.5% CV or SD
< 0.005 g/L1
< 10% CV < 10% CV N/A N/A
Urine N/A N/A N/A N/A < 10% CV < 10% CV
CSF < 6% < 6% N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 Serum: R1 = 110 μL, R2 = 100 μL
CSF: R1 = 110 μL, R2 = 68 μL
R1 = 70 μL, R2 = 55 μL R1 = 150 μL, R2 = 50 μL
AU480/AU680/AU2700/AU5400 Serum: R1 = 87 μL, R2 = 80 μL
CSF: R1 = 110 μL, R2 = 68 μL
R1 = 56 μL, R2 = 44 μL R1 = 120 μL, R2 = 40 μL
Cartridge/Kit Size
AU400/AU600/AU640 OSR61172 (4 x 200 tests) OSR61173 (4 x 200 tests) OSR6167 (4 x 100 tests)
AU480/AU680/AU2700/AU5400 OSR61172 (4 x 250 tests) OSR61173 (4 x 250 tests) OSR6167 (4 x 125 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 90 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency Serum/Plasma: 90 days
CSF: 2 days
90 days 90 days
Reagent Blank Frequency Serum/Plasma: 90 days
CSF: 2 days
90 days 90 days
Compatible Anticoagulants EDTA
Lithium Heparin
EDTA
Lithium Heparin
N/A
Calibrator Part Number ODR3021 ODR3021 ODR3024
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) 1 Use the greater number
21
Proteins/Serology
Chemistry Name Prealbumin Rheumatoid Factor Transferrin
Chemistry Abbreviation PALB RF TRF
Measurement Principle Immunoturbidimetric Latex Particle Immunoturbidimetric Immunoturbidimetric
Reaction Type End Fixed End
Primary Wavelength 340 nm 660 nm 380 nm
Measuring Points 0, 27/0, 10 12, 19 0, 27/0, 10
Sample Type Serum Serum/Plasma Serum
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3 μL 3 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2.4 μL 2.6 μL 1.6 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 17-34 mg/dL 0.17-0.34 g/L ≤ 14 IU/mL ≤ 14 IU/mL 203-362 mg/dL 2.0-3.6 g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 3-80 mg/dL 0.03-0.80 g/L 10-120 IU/L 10-120 IU/L 75-750 mg/dL 0.75-7.5 g/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 10% CV < 10% CV < 10% CV < 10% CV < 5% CV < 5% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 150 μL, R2 = 65 μL R1 = 120 μL, R2 = 40 μL1 R1 = 35 μL, R2 = 40 μL
AU480/AU680/AU2700/AU5400 R1 = 120 μL, R2 = 52 μL R1 = 96 μL, R2 = 32 μL1 R1 = 28 μL, R2 = 32 μL
Kit Size
AU400/AU600/AU640 OSR6175 (4 x 100 tests) OSR61105 (4 x 200 tests) OSR6152 (4 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR6175 (4 x 120 tests) OSR61105 (4 x 250 tests) OSR6152 (4 x 270 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 60 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 90 days 30 days 90 days
Reagent Blank Frequency 90 days 90 days 90 days
Compatible Anticoagulants N/A Lithium Heparin
EDTA
N/A
Calibrator Part Number ODR3029 ODC0028 ODR3021
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) 1 Gently invert R2 5-10 times before
placing on instrument and weekly
22
Esoterics
Chemistry Name Ammonia Cholinesterase Creatine Kinase MB
Chemistry Abbreviation AMMON CHE CKMB
Measurement Principle Enzymatic Glutamate Dehydrogenase Butyrylthiocholine Immuno-inhibition UV/NADP
Reaction Type Fixed Rate Rate
Primary Wavelength 340 nm 410 nm 340 nm
Measuring Points 2, 7 16, 20 21, 27
Sample Type Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 30 μL 3 μL 6 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 25 μL 3 μL 5 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 25-90 μg/dL 16-53 μmol/L 4.9-11.9 kU/L 82-198 μkat/L 0-10 U/L 0-0.167 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 17-1020 μg/dL 10-600 μmol/L 1-15 kU/L 17-250 μkat/L 10-2000 U/L 0.17-33.3 μkat/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma < 5% CV < 5% CV < 10% CV < 10% CV < 6.5% CV or SD
≤ 2 U/L1
< 6.5% CV or SD
≤ 0.03 μkat/L1
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 150 R1 = 150 μL, R2 = 30 μL R1 = 120 μL, R2 = 30 μL2
AU480/AU680/AU2700/AU5400 R1 = 125 R1 = 150 μL, R2 = 30 μL R1 = 100 μL, R2 = 25 μL2
Cartridge Part Number/Size
AU400/AU600/AU640 OSR61154 (2 x 106 tests) OSR6114 (4 x 200 tests) OSR61155 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR61154 (2 x 106 tests) OSR6114 (4 x 200 tests) OSR61155 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 14 days 30 days 30 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 7 days N/A N/A
Reagent Blank Frequency 7 days 1 day 5 days
Compatible Anticoagulants EDTA
Lithium Heparin
Heparin
EDTA
Heparin
Calibrator Part Number Included N/A N/A
Control Name Bio-Rad* Bio-Rad* No specific recommendation
Control Part Number N/A N/A N/A
Comment(s) 1 Use the greater number2 Transfer R1-2 into R1-1
23
Esoterics
Chemistry Name Hemoglobin A1c Lactate Lithium
Chemistry Abbreviation HBA1C LAC LI
Measurement Principle Turbidimetric Immuno-inhibition Enzymatic Colorimetric/Endpoint
Reaction Type Thb: End
HbA1c: Fixed
Fixed End
Primary Wavelength Thb: 600 nm
HbA1c: 700 nm
540 nm 520 nm
Measuring Points THb: 0, 27
HbA1c: 13, 22
1, 15 0, 6
Sample Type Pre-treated Whole Blood Plasma/CSF Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A 2 μL 2 μL of a 1/10
Urine N/A N/A N/A
CSF N/A 2 μL N/A
Other THb: 11.0 μL1
HbA1c: 3.5 μL1
N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A 1.6 μL 2 μL of a 1/10
Urine N/A N/A N/A
CSF N/A 1.6 μL N/A
Other THb: 9.5 μL1
HbA1c: 3 μL1
N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma N/A N/A 4.5-19.8 mg/dL 0.5-2.2 mmol/L 1.0-1.2 mmol/L
(trough)
1.0-1.2 mEq/L
(trough)
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A Neonate:
10-60 mg/dL
3-10 days old:
10-40 mg/dL
> 10 days old:
10-25 mg/dL
Adult: 10-22 mg/dL
Neonate:
1.1-6.7 mmol/L
3-10 days old:
1.1-4.4 mmol/L
> 10 days old:
1.1-2.8 mmol/L
Adult: 1.1-2.4
mmol/L
N/A N/A
Other HbA1c: 4.0-6.2% HbA1c: 4.0-
6.2%
N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma N/A N/A 2-90 mg/dL 0.2-10 mmol/L 0.1-5.0 mmol/L 0.1-5.0 mEq/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A 2-90 mg/dL 0.2-10 mmol/L N/A N/A
Other 2.6% - highest
calibrator
2.6% - highest
calibrator
N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma ≤ 4% CV ≤ 4% CV < 5% CV < 5% CV < 5% CV < 5% CV
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 THb: R1 = 150
HbA1c: R1 = 76, R2 = 762
R1 = 200 R1 = 150
AU480/AU680/AU2700/AU5400 THb: R1 = 130
HbA1c: R1 = 65, R2 = 652
R1 = 160 R1 = 150
Cartridge Part Number/Size
AU400/AU600/AU640 OSR6192 (2 x 250 tests) OSR6193 (4 x 50 tests) OSRT056 (2 x 113 tests
AU480/AU680/AU2700/AU5400 OSR6192 (2 x 250 tests) OSR6193 (4 x 60 tests) OSRT056 (2 x 113 tests)
Liquid or Lyophilized Liquid Lyophilized Liquid
On-Instrument Stability 30 days 30 days 14 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 30 days 7 days
Reagent Blank Frequency 14 days 30 days 7 days
Compatible Anticoagulants K2 EDTA
NH4 Heparinized Whole Blood
Sodium Fluoride
Potassium Oxalate
EDTA
Calibrator Part Number ODR3032 DR0070-2 Included
Control Name HbA1c Control Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number ODC0022 N/A N/A
Comment(s) 1 Whole blood values 2 Gently invert R2 5-10 times before
placing on instrument and weekly
24
Thyroids
Chemistry Name Thyroxine T-Uptake
Chemistry Abbreviation T4 TUP
Measurement Principle Homogenous Enzymatic Immunoassay Homogenous Enzymatic Immunoassay
Reaction Type Fixed 1 Fixed 1
Primary Wavelength 340 nm 340 nm
Measuring Points 14, 20 14, 20
Sample Type Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 4 μL 8 μL
Urine N/A N/A
CSF N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 4 μL 8 μL
Urine N/A N/A
CSF N/A N/A
Reference Interval SI Units SI Units
Serum/Plasma 4.5-12 μg/dL 58-154 nmol/L 23-36% 23-36%
Urine N/A N/A N/A N/A
CSF N/A N/A N/A N/A
Analytical Range SI Units SI Units
Serum/Plasma 0.7-20 μg/dL 9-257 nmol/L 15-50% 15-50%
Urine N/A N/A N/A N/A
CSF N/A N/A N/A N/A
Precision Specification SI Units SI Units
Serum/Plasma typical CV ≤ 4.3% typical CV
≤ 4.3%
typical CV ≤ 3.6% typical CV
≤ 3.6%
Urine N/A N/A N/A N/A
CSF N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 180, R2 = 60 R1 = 180, R2 = 60
AU480/AU680/AU2700/AU5400 R1 = 180, R2 = 60 R1 = 180, R2 = 60
Cartridge Part Number/Size
AU400/AU600/AU640 0454 (510 tests) 0723 (510 tests)
AU480/AU680/AU2700/AU5400 0454 (510 tests) 0723 (510 tests)
Liquid or Lyophilized Liquid Liquid
On-Instrument Stability 60 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days
Reagent Blank Frequency 14 days 14 days
Compatible Anticoagulants Heparin
Citrate
Oxalate
EDTA
Heparin
Citrate
Oxalate
EDTA
Calibrator Part Number 0476 0738
Control Name Bio-Rad*/MAS Bio-Rad*/MAS
Control Part Number N/A N/A
Comment(s) User-defined reagent User-defined reagent
25
Therapeutic Drug Monitoring (TDM)
Chemistry Name Acetaminophen Amikacin Caffeine
Chemistry Abbreviation ACETA AMIK CAFF
Measurement Principle Emit* tox Emit* TDM Emit* TDM
Reaction Type Rate Rate Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 23 12, 16 12, 16
Sample Type Serum/Plasma Serum/Plasma Serum
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3 μL 3 μL 3 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 3 μL (AU480: 2.4 μL) 3 μL (AU480: 1.7 μL) 3 μL (AU480: 1.7 μL)
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma Consult literature Consult
literature
Consult literature Consult
literature
Consult literature Consult
literature
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 10-200 μg/mL 66-1324 μmol/L 2.5-50 μg/mL 4.3-85.5 μmol/L 1-30 μg/mL 5-155 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma typical CV ≤ 5% typical CV ≤ 5% typical CV ≤ 3.9% typical CV ≤ 3.9% typical CV ≤ 4.2% typical CV ≤ 4.2%
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 150, R2 = 75 R1 = 162, R2 = 162 R1 = 162, R2 = 162
AU480/AU680/AU2700/AU5400 R1 = 150, R2 = 75
(AU480: R1 = 120, R2 = 60)
R1 = 162, R2 = 162
(AU480: R1 = 89, R2 = 89)
R1 = 162, R2 = 162
(AU480: R1 =89, R2 = 89)
Kit Part Number/Size
AU400/AU600/AU640 OSR7A229 (2 x 200 tests) 6X019 (275 tests) 6P419 (145 tests)
AU480/AU680/AU2700/AU5400 OSR7A229 (2 x 200 tests) 6X019 (275 tests) 6P419 (145 tests)
Liquid or Lyophilized Liquid Lyophilized Lyophilized
On-Instrument Stability 28 days 28 days 28 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants EDTA
Heparin
Citrate
Oxalate/Fluoride
EDTA
Citrate
Oxalate
N/A
Calibrator Part Number 7A409 Included Included
Control Name Bio-Rad*/MAS Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) User-defined reagent User-defined reagent
26
Therapeutic Drug Monitoring (TDM)
Chemistry Name Carbamazepine Digoxin Disopyramide
Chemistry Abbreviation CARB DIG DISO
Measurement Principle Emit* 2000 Emit* 2000 Emit* TDM
Reaction Type Rate Rate Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 19, 27 17, 27 12, 16
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 17 μL 3 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2 μL (AU480: 1.6 μL) 17 μL (AU480: 13.6 μL) 3 μL (AU480: 1.7 μL)
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 4-12 μg/mL 17-51 μmol/L 0.9-2.0 ng/mL 1.2-2.6 nmol/L 3-5 μg/mL 9-15 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 2-20 μg/mL 8.5-84.6 μmol/L 0.2-5.0 ng/mL 0.3-6.4 nmol/L 0.5-8 μg/mL 1.5-23.6 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma typical CV ≤ 6.5% typical CV ≤ 6.5% typical CV ≤ 10.4% typical CV ≤ 10.4% typical CV ≤ 4.6% typical CV ≤ 4.6%
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 100, R2 = 50 R1 = 130, R2 = 50 R1 = 162, R2 = 162
AU480/AU680/AU2700/AU5400 R1 = 100, R2 = 50
(AU480: R1 = 80, R2 = 40)
R1 = 130, R2 = 50
(AU480: R1 = 104, R2 = 40)
R1 = 162, R2 = 162
(AU480: R1 =89, R2 = 89)
Kit Part Number/Size
AU400/AU600/AU640 OSR4F229 (2 x 200 tests) OSR4H229 (2 x 200 tests) 6N319 (275 tests)
AU480/AU680/AU2700/AU5400 OSR4F229 (2 x 200 tests) OSR4H229 (2 x 200 tests) 6N319 (275 tests)
Liquid or Lyophilized Liquid Liquid Lyophilized
On-Instrument Stability 90 days 90 days 28 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants Heparin
Oxalate
Citrate
EDTA
Heparin
Oxalate
EDTA
Heparin
EDTA
Oxalate
Calibrator Part Number 4F109 4H209 Included
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) User-defined reagent
27
Therapeutic Drug Monitoring (TDM)
Chemistry Name Ethosuximide Gentamicin Lidocaine
Chemistry Abbreviation SUXI GENT LIDO
Measurement Principle Emit* TDM Emit* 2000 Emit* TDM
Reaction Type Rate Rate Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 12, 16 19, 27 12, 16
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 4.5 μL 2 μL 3 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 4.5 μL (AU480: 2.5 μL) 2 μL (AU480: 1.6 μL) 3 μL (AU480: 1.7 μL)
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 40-100 μg/mL 283-708 μmol/L Peak 4.0-8.0
μg/mL
Peak 8.6-17.0
μmol/L
1.5-5.0 μg/mL 6-21 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 10-150 μg/mL 71-1062 μmol/L 0.25-10 μg/mL 0.5-20.9 μmol/L 1-12 μg/mL 4.3-51.2 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma typical CV ≤ 4.7% typical CV ≤ 4.7% typical CV ≤ 6.3% typical CV ≤ 6.3% typical CV ≤ 4.6% typical CV ≤ 4.6%
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 200, R2 = 200 R1 = 100, R2 = 50 R1 = 162, R2 = 162
AU480/AU680/AU2700/AU5400 R1 = 200, R2 = 200
(AU480: R1 = 110, R2 = 110)
R1 = 100, R2 = 50
(AU480: R1 = 80, R2= 40)
R1 = 162, R2 = 162
(AU480: R1 = 89, R2 = 89)
Kit Part Number/Size
AU400/AU600/AU640 6E119 (120 tests) OSR4T229 (2 x 200 tests) 6M119 (145 tests)
AU480/AU680/AU2700/AU5400 6E119 (120 tests) OSR4T229 (2 x 200 tests) 6M119 (145 tests)
Liquid or Lyophilized Lyophilized Liquid Lyophilized
On-Instrument Stability 56 days and as required 90 days 28 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants Heparin
EDTA
Heparin
Citrate
Oxalate
EDTA
Heparin
EDTA
Oxalate
Calibrator Part Number 6A089 4T209 Included
Control Name Bio-Rad* Bio-Rad*/MAS Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) User-defined reagent User-defined reagent
28
Therapeutic Drug Monitoring (TDM)
Chemistry Name Methotrexate N-Acetylprocainamide Phenobarbital
Chemistry Abbreviation MTRX NAPA PBARB
Measurement Principle Emit* TDM Emit* 2000 Emit* 2000
Reaction Type Rate Rate Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 12, 16 19, 27 15, 19
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3.0 μL 2 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 3.0 μL (AU480: 1.7 μL) 2 μL (AU480: 1.6 μL) 2 μL (AU480: 1.6 μL)
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma Consult literature Consult
literature
Consult literature Consult
literature
10-40 μg/mL 43-172 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 0.3-2600 μmol/L 3 x 10-7 – 2.6 x
10-3 mol/L)
1-16 μg/mL 3.6-57.8 μmol/L 5-80 μg/mL 22-345 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma typical CV ≤ 4.4% typical CV ≤ 4.4% typical CV ≤ 4.5% typical CV ≤ 4.5% typical CV ≤ 5.5% typical CV ≤ 5.5%
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 162, R2 = 162 R1 = 100, R2 = 50 R1 = 90, R2 = 90
AU480/AU680/AU2700/AU5400 R1 = 162, R2 = 162
(AU480: R1 = 89, R2 = 89)
R1 = 100, R2 = 50
(AU480: R1 = 80, R2 = 40)
R1= 90, R2 = 90
(AU480: R1 = 72, R2 = 72)
Kit Part Number/Size
AU400/AU600/AU640 6L119 (130 tests) OSR4N229 (2 x 200 tests) OSR4D229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 6L119 (130 tests) OSR4N229 (2 x 200 tests) OSR4D229 (2 x 200 tests)
Liquid or Lyophilized Lyophilized Liquid Liquid
On-Instrument Stability 28 days 90 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants Heparin
EDTA
Oxalate
Heparin
Citrate
Oxalate
EDTA
Heparin
Citrate
Oxalate
EDTA
Calibrator Part Number Included 4N109 4D109
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) User-defined reagent
29
Therapeutic Drug Monitoring (TDM)
Chemistry Name Phenytoin Primidone Procainamide
Chemistry Abbreviation PHENY PRIM PROC
Measurement Principle Emit* 2000 Emit* TDM Emit* 2000
Reaction Type Rate Rate Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 19, 27 12, 16 19, 27
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 4 μL 2 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2 μL (AU480: 1.6 μL) 4 μL (AU480: 2.4 μL) 2 μL (AU480: 1.6 μL)
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 10-20 μg/mL 40-79 μmol/L 5-12 μg/mL 23-55 μmol/L 4-10 μg/mL 17-43 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 2.5-40 μg/mL 10-158 μmol/L 2.5-20 μg/mL 11-92 μmol/L 1-12 μg/mL 4.3-51 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma typical CV ≤ 8.2% typical CV ≤ 8.2% typical CV ≤ 6.2% typical CV ≤ 6.2% typical CV ≤ 7.9% typical CV ≤ 7.9%
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 90, R2 = 65 R1 = 100, R2 = 100 R1 = 100, R2 = 50
AU480/AU680/ AU2700/AU5400 R1 = 90, R2 = 65
(AU480: R1 = 72, R2 = 52)
R1 = 100, R2 = 100
(AU480: R1 = 60, R2 = 60)
R1 = 100, R2 = 50
(AU480: R1 = 80, R2 = 40)
Kit Part Number/Size
AU400/AU600/AU640 OSR4A229 (2 x 200 tests) 6C119 (240 tests) OSR4K229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR4A229 (2 x 200 tests) 6C119 (240 tests) OSR4K229 (2 x 200 tests)
Liquid or Lyophilized Liquid Lyophilized Liquid
On-Instrument Stability 90 days 84 days and as required 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 7 days 14 days
Reagent Blank Frequency 14 days 7 days 14 days
Compatible Anticoagulants Heparin
Citrate
Oxalate
EDTA
Heparin
EDTA
Heparin
Citrate
Oxalate
EDTA
Calibrator Part Number 4A109 6A089 4K109
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s) User-defined reagent
30
Therapeutic Drug Monitoring (TDM)
Chemistry Name Quinidine Salicylic Acid Theophylline
Chemistry Abbreviation QUIN SALI THEO
Measurement Principle Emit* 2000 Emit* tox Emit* 2000
Reaction Type Rate Rate Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 11, 15 15, 23 15, 19
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2 μL 3 μL 3 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2 μL (AU480: 1.6 μL) 3 μL ( AU480: 2.4 μL) 3 μL (AU480: 2.4 μL)
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma 2 – 5 μg/mL 6.2-15 μmol/L < 6 mg/dL < 434 μmol/L 10-20 μg/mL 56-111 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 0.5-8 μg/mL 1.5-25 μmol/L 2.5-80 mg/dL 181-5792 μmol/L 2.5-40 μg/mL 14-222 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma typical CV ≤ 9.3% typical CV ≤ 9.3% < 8.5% CV < 8.5% CV typical CV ≤ 11.3% typical CV ≤ 11.3%
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 100, R2 = 50 R1 = 150, R2 = 75 R1 = 100, R2 = 50
AU480/AU680/AU2700/AU5400 R1 = 100, R2 = 50
(AU480: R1 = 80, R2 = 40)
R1 = 150, R2 = 75
(AU480: R1 = 120, R2 = 60)
R1 = 100, R2 = 50
(AU480: R1 = 80, R2 = 40)
Kit Part Number/Size
AU400/AU600/AU640 OSR4Q229 (2 x 200 tests) OSR7S229 (2 x 200 tests) OSR4P229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR4Q229 (2 x 200 tests) OSR7S229 (2 x 200 tests) OSR4P229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 28 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants Heparin
Citrate
Oxalate
EDTA
EDTA
Sodium Heparin
Citrate
Oxalate/Fluoride
Heparin
Citrate
Oxalate
EDTA
Calibrator Part Number 4Q109 7S109 4P109
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s)
31
Therapeutic Drug Monitoring (TDM)
Chemistry Name Tobramycin Valproic Acid Vancomycin
Chemistry Abbreviation TOB VPA VANC
Measurement Principle Emit* 2000 Emit* 2000 Emit* 2000
Reaction Type Rate Rate Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 17, 25 12, 17 15, 21
Sample Type Serum/Plasma Serum/Plasma Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3.5 μL 3.5 μL 3 μL
Urine N/A N/A N/A
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 3.5 μL (AU480: 2.8 μL) 3.5 μL (AU480: 2.8 μL) 3 μL (AU480: 2.4 μL)
Urine N/A N/A N/A
CSF N/A N/A N/A
Reference Interval SI Units SI Units SI Units
Serum/Plasma Peak 4-8 μg/mL Peak 8.6-17.1
μmol/L
50-100 μg/mL 347-693 μmol/L Consult literature Consult
literature
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Analytical Range SI Units SI Units SI Units
Serum/Plasma 0.6-10 μg/mL 1.3-21.4 μmol/L 10-150 μg/mL 69-1040 μmol/L 2-50 μg/mL 1.3-34 μmol/L
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Precision Specification SI Units SI Units SI Units
Serum/Plasma typical CV ≤ 6.8% typical CV ≤ 6.8% typical CV ≤ 4.3% typical CV
≤ 4.3%
typical CV ≤ 3.8% typical CV
≤ 3.8%
Urine N/A N/A N/A N/A N/A N/A
CSF N/A N/A N/A N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 174, R2 = 87 R1 = 174, R2 = 87 R1 = 150, R2 = 80
AU480/AU680/AU2700/AU5400 R1 = 174, R2 = 87
(AU480: R1 = 139, R2 = 70)
R1 = 174, R2 = 87
(AU480: R1 = 139, R2 = 70)
R1 = 150, R2 = 80
(AU480: R1 = 120, R2 = 64)
Kit Part Number/Size
AU400/AU600/AU640 OSR4S229 (2 x 200 tests) OSR4G229 (2 x 200 tests) OSR4W229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR4S229 (2 x 200 tests) OSR4G229 (2 x 200 tests) OSR4W229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 90 days 90 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants Sodium Heparin
Citrate
Oxalate/Fluoride
EDTA
EDTA
Heparin
Citrate
Oxalate/Fluoride
EDTA
Sodium Heparin
Lithium Heparin
Citrate
Oxalate/Fluoride
Calibrator Part Number 4S109 4G109 4W109
Control Name Bio-Rad* Bio-Rad* Bio-Rad*
Control Part Number N/A N/A N/A
Comment(s)
32
Drugs of Abuse Testing (DAT)
Chemistry NameAmphetamines
(300 cutoff)
Amphetamines
(500 cutoff)
Amphetamines
(1000 cutoff)
Chemistry Abbreviation AMPH+ AMPH+ AMPH+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 13, 15 13, 15 13, 15
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 5.0 μL 3.0 μL 2.0 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 5.0 μL (AU480: 3.5 μL) 3.0 μL (AU480: 2.1 μL) 2.0 μL (AU480: 1.6 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 300 ng/mL 500 ng/mL 1000 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 150, R2 = 65 R1 = 150, R2 = 65 R1 = 158, R2 = 68
AU480/AU680/AU2700/AU5400
R1 = 150, R2 = 65
(AU480: R1 = 105, R2 = 46)
R1 = 150, R2 = 65
(AU480: R1 = 105, R2 = 46)
R1 = 158, R2 = 68
(AU480: R1 = 126, R2 = 54)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 28 days 28 days 28 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A529 9A549 9A569
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
33
Drugs of Abuse Testing (DAT)
Chemistry NameAmphetamines
(300 cutoff/semi-quantitative)
Amphetamines
(500 cutoff/semi-quantitative)
Amphetamines
(1000 cutoff/semi-quantitative)
Chemistry Abbreviation AMPH+ AMPH+ AMPH+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 13, 15 13, 15 13, 15
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 5.0 μL 3.0 μL 2.0 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 5.0 μL (AU480: 3.5 μL) 3.0 μL (AU480: 2.1 μL) 2.0 μL (AU480: 1.6 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 300 ng/mL 500 ng/mL 1000 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 150, R2 = 65 R1 = 150, R2 = 65 R1 = 158, R2 = 68
AU480/AU680/AU2700/AU5400
R1 = 150, R2 = 65
(AU480: R1 = 105, R2 = 46)
R1 = 150, R2 = 65
(AU480: R1 = 105, R2 = 46)
R1 = 158, R2 = 68
(AU480: R1 = 126, R2 = 54)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests) OSR9C229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 28 days 28 days 28 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A529, 9A549, 9A569 9A529, 9A549, 9A569 9A529, 9A549, 9A569, 9A609
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
34
Drugs of Abuse Testing (DAT)
Chemistry NameBarbiturate
(200 cutoff)
Barbiturate
(300 cutoff)
Barbiturate
(semi-quantitative)
Chemistry Abbreviation BARB+ BARB+ BARB+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 19 15, 19 15, 19
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 6.0 μL 6.0 μL 6.0 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 6.0 μL (AU480: 4.2 μL) 6.0 μL (AU480: 4.2 μL) 6.0 μL (AU480: 4.2 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 200 ng/mL 300 ng/mL 200/300 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 140, R2 = 60 R1 = 140, R2 = 60
AU480/AU680/AU2700/AU5400
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
R1= 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests) OSR9D229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 60 days 60 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A569 9A589 9A549, 9A569, 9A589, 9A609
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
35
Drugs of Abuse Testing (DAT)
Chemistry Name Barbiturate, ToxBenzodiazepine
(200 cutoff)
Benzodiazepine
(300 cutoff)
Chemistry Abbreviation TBARB BENZ+ BENZ+
Measurement Principle Emit* tox Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 12, 16 15, 19 15, 19
Sample Type Serum/Plasma Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma 3 μL N/A N/A
Urine N/A 6 μL 6 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 3 μL (AU480: 2.4 μL) N/A N/A
Urine N/A 6 μL (AU480: 4.2 μL) 6 μL (AU480: 4.2 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine N/A 200 ng/mL 300 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma User defined N/A N/A
Urine N/A User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 100, R2 = 100 R1 = 140, R2 = 60 R1 = 140, R2 = 60
AU480/AU680/AU2700/AU5400
R1 = 100, R2 = 100
(AU480: R1 = 80, R2 = 80)
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
Cartridge Part Number/Size
AU400/AU600/AU640 7D119 (235 tests) OSR9F229 (2 x 200 tests) OSR9F229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 7D119 (235 tests) OSR9F229 (2 x 200 tests) OSR9F229 (2 x 200 tests)
Liquid or Lyophilized Lyophilized Liquid Liquid
On-Instrument Stability 35 days 60 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 1 day 14 days 14 days
Reagent Blank Frequency 1 day 14 days 14 days
Compatible Anticoagulants Heparin
Oxalate
EDTA
N/A N/A
Calibrator Part Number 7B019 9A569 9A589
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s) User-defined reagent
36
Drugs of Abuse Testing (DAT)
Chemistry NameBenzodiazepine
(semi-quantitative)Benzodiazepine, Tox
Cannabinoid
(20 cutoff)
Chemistry Abbreviation BENZ+ TBENZ THC20+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 19 13, 15 15, 20
Sample Type Urine Serum/Plasma Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A 2.5 μL N/A
Urine 6 μL N/A 10 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A 2.5 μL (AU480: 2 μL) N/A
Urine 6 μL (AU480: 4.2 μL) N/A 10 μL (AU480: 7 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 200/300 ng/mL N/A 20 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A User defined N/A
Urine User defined N/A User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 75, R2 = 75 R1 = 140, R2 = 60
AU480/AU680/AU2700/AU5400
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
R1 = 75, R2 = 75
(AU480: R1 = 60, R2 = 60)
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9F229 (2 x 200 tests) 7B119 (300 tests) OSR9N229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9F229 (2 x 200 tests) 7B119 (300 tests) OSR9N229 (2 x 200 tests)
Liquid or Lyophilized Liquid Lyophilized Liquid
On-Instrument Stability 60 days 35 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 1 day 14 days
Reagent Blank Frequency 14 days 1 day 14 days
Compatible Anticoagulants N/A Oxalate
EDTA
Heparin
N/A
Calibrator Part Number 9A549, 9A569, 9A589, 9A609 7B019 9A549
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s) User-defined reagent
37
Drugs of Abuse Testing (DAT)
Chemistry NameCannabinoid
(50 cutoff)
Cannabinoid
(100 cutoff)
Cannabinoid
(semi-quantitative)
Chemistry Abbreviation THC50+ THC100+ THC50+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 20 15, 20 15, 20
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 4.5 μL 3.5 μL 4.5 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 4.5 μL (AU480: 3.2 μL) 3.5 μL (AU480: 2.5 μL) 4.5 μL (AU480: 3.2 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 50 ng/mL 100 ng/mL 20/50/100 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 160, R2 = 40 R1 = 140, R2 = 60
AU480/AU680/AU2700/AU5400
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
R1 = 160, R2 = 40
(AU480: R1 = 112, R2 = 28)
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests) OSR9N229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 60 days 60 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A569 9A589 9A569, 9A589, 9A609
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
38
Drugs of Abuse Testing (DAT)
Chemistry NameCocaine Metabolite
(150 cutoff)
Cocaine Metabolite
(300 cutoff)
Cocaine Metabolite
(semi-quantitative)
Chemistry Abbreviation COCA+ COCA+ COCA+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 19 15, 19 15, 19
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 9 μL 9 μL 9 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 9 μL (AU480: 6.3 μL) 9 μL (AU480: 6.3 μL) 9 μL (AU480: 6.3 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 150 ng/mL 300 ng/mL 150/300 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 130, R2 = 55 R1 = 130, R2 = 55 R1 = 130, R2 = 55
AU480/AU680/AU2700/AU5400
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests) OSR9H229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 60 days 60 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A549 9A569 9A549, 9A569, 9A589, 9A609
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
39
Drugs of Abuse Testing (DAT)
Chemistry Name Creatinine, ToxEcstasy
(300 cutoff)
Ecstasy
(500 cutoff)
Chemistry Abbreviation CRTOX XTC XTC
Measurement Principle Modified Jaffe, Kinetic Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 520 nm 340 nm 340 nm
Measuring Points 13, 17 13, 15 13, 15
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 3 μL 7 μL 5 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 3 μL 7 μL (AU480: 4.9 μL) 5 μL (AU480: 3.5 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine N/A 300 ng/mL 500 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine 1-100 mg/dL User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 50, R2 = 50 R1 = 130, R2 = 55 R1 = 130, R2 = 55
AU480/AU680/AU2700/AU5400
R1 = 50, R2 = 50 R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR66100 (4 x 3070 tests)1 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR66100 (4 x 3070 tests)1 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 14 days 28 days 28 days
Storage Temperature +15 to +25°C +2 to +8°C +2 to +8°C
Calibration Frequency 7 days 14 days 14 days
Reagent Blank Frequency 7 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number Syva* cR Perfect* Calibrators: (3T129,
3T249, 3T139, 3T149)
9A509, 9X549, 9X589 9A509, 9X569, 9X589
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s) 1 Available as user-defined reagent for
AU400/AU600/AU640/AU480/AU680
40
Drugs of Abuse Testing (DAT)
Chemistry NameEcstasy
(300 cutoff/semi-quantitative)
Ecstasy
(500 cutoff/semi-quantitative)Ethyl Alcohol
Chemistry Abbreviation XTC XTC ETOH+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 13, 15 13, 15 12, 16
Sample Type Urine Urine Serum/Plasma/Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A 4 μL
Urine 7 μL 5 μL 4 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A 4 μL (AU480: 2.8 μL)
Urine 7 μL (AU480: 4.9 μL) 5 μL (AU480: 3.5 μL) 4 μL (AU480: 2.8 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 300 ng/mL 500 ng/mL N/A
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A 10-600 mg/dL
Urine User defined User defined 10-600 mg/dL
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 130, R2 = 55 R1 = 130, R2 = 55 R1 = 210, R2 = 90
AU480/AU680/AU2700/AU5400
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
R1 = 210, R2 = 90
(AU480: R1 = 147, R2 = 63)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests) OSR9K229 (2 x 130 tests)
AU480/AU680/AU2700/AU5400 OSR9X229 (2 x 200 tests) OSR9X229 (2 x 200 tests) OSR9K229 (2 x 130 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 28 28 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A Heparin
Oxalate/Fluoride
EDTA
Citrate
Calibrator Part Number 9A509, 9X529, 9X549, 9X569 9A529, 9X549, 9X569, 9X589 9K029, 9K059
Control Name No specific recommendation No specific recommendation Ethyl Alcohol Low Control
Ethyl Alcohol High Control
Control Part Number N/A N/A 9K049
9K079
Comment(s)
41
Drugs of Abuse Testing (DAT)
Chemistry NameLSD
(0.5 cutoff)
LSD
(semi-quantitative)
Methadone
(150 cutoff)
Chemistry Abbreviation LSD LSD2 METH+
Measurement Principle Emit II* Emit II* Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 17, 27 22, 27 15, 19
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 20 μL 20 μL 6 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 20 μL (AU480: 16 μL) 20 μL (AU480: 16 μL) 6 μL (AU480: 4.2 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 0.5 ng/mL 0.5 ng/mL 150 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 100, R2 = 50 R1 = 100, R2 = 50 R1 = 140, R2 = 60
AU480/AU680/AU2700/AU5400 R1 = 100, R2 = 50
(AU480: R1 = 80, R2 = 40)
R = 100, R2 = 50
(AU480: R1 = 80, R2 = 40)
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
Cartridge Part Number/Size
AU400/AU600/AU640 9L019 (460 tests) 9L019 (460 tests) OSR9E229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 9L019 (460 tests) 9L019 (460 tests) OSR9E229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 90 days 90 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 1 day 1 day 14 days
Reagent Blank Frequency 1 day 1 day 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9L009, 9L209, 9L309 9L009, 9L109, 9L209, 9L309 9A549
Control Name LSD Level I Control
LSD Level II Control
LSD Level I Control
LSD Level II Control
No specific recommendation
Control Part Number 9L419
9L519
9L419
9L519
N/A
Comment(s) User-defined reagent User-defined reagent
42
Drugs of Abuse Testing (DAT)
Chemistry NameMethadone
(300 cutoff)
Methadone
(semi-quantitative)
Methaqualone
(300 cutoff)
Chemistry Abbreviation METH+ METH+ METQ+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 19 15, 19 15, 19
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 6 μL 6 μL 5.5 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 6 μL (AU480: 4.2 μL) 6 μL (AU480: 4.2 μL) 5.5 μL (AU480: 3.9 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 300 ng/mL 150/300 ng/mL 300 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 140, R2 = 60 R1 = 140, R2 = 60 R1 = 130, R2 = 55
AU480/AU680/AU2700/AU5400
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
R1 = 140, R2 = 60
(AU480: R1 = 98, R2 = 42)
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9E229 (2 x 200 tests) OSR9E229 (2 x 200 tests) OSR9Q229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9E229 (2 x 200 tests) OSR9E229 (2 x 200 tests) OSR9Q229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 60 days 60 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A569 9A549, 9A569, 9A589, 9A609 9A569
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
43
Drugs of Abuse Testing (DAT)
Chemistry NameMethaqualone
(semi-quantitative)
Opiates
(300 cutoff)
Opiates
(2000 cutoff)
Chemistry Abbreviation METQ+ OPIA+ OPIA+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 19 16, 22 16, 22
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 5.5 μL 8 μL 3 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 5.5 μL (AU480: 3.9 μL) 8 μL (AU480: 5.6 μL) 3 μL (AU480: 2.1 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 300 ng/mL 300 ng/mL 2000 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 130, R2 = 55 R1 = 134, R2 = 50 R1 = 200, R2 = 75
AU480/AU680/AU2700/AU5400
R1 = 130, R2 = 55
(AU480: R1 = 91, R2 = 39)
R1 = 134, R2 = 50
(AU480: R1 = 94, R2 = 35)
R1 = 200, R2 = 75
(AU480: R1 = 140, R2 = 53)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9Q229 (2 x 200 tests) OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9Q229 (2 x 200 tests) OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 60 days 28 days 28 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A549, 9A569, 9A589, 9A609 9A529 9A569
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
44
Drugs of Abuse Testing (DAT)
Chemistry NameOpiates
(300 cutoff/semi-quantitative)
Opiates
(2000 cutoff/semi-quantitative)
Oxycodone
(100 cutoff)
Chemistry Abbreviation OPIA+ OPIA+ OXY
Measurement Principle Emit ll* Plus Emit ll* Plus Homogeneous enzyme immunoassay
Reaction Type Fixed Fixed Rate
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 16, 22 16, 22 17, 21
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 8 μL 3 μL 14 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 8 μL (AU480: 5.6 μL) 3 μL (AU480: 2.1 μL) 14 μL
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 300 ng/mL 2000 ng/mL 100 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 134, R2 = 50 R1 = 200, R2 = 75 R1 = 87, R2 = 87
AU480/AU680/AU2700/AU5400
R1 = 134, R2 = 50
(AU480: R1 = 94, R2 = 35)
R1 = 200, R2 = 75
(AU480: R1 = 140, R2 = 53)
R1 = 87, R2 = 87
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests) 100248-(DRI) 70 mL kit (650 tests/kit)
100249-(DRI) 500 mL kit (5400 tests/kit)
AU480/AU680/AU2700/AU5400 OSR9B229 (2 x 200 tests) OSR9B229 (2 x 200 tests) 100248-(DRI) 70 mL kit (650 tests/kit)
100249-(DRI) 500 mL kit (5400 tests/kit)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 28 days 28 days 30 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A509, 9A529, 9A549, 9A569 9A509, 9A549, 9A569, 9A609 DRI* Calibrator: 100250
Control Name No specific recommendation No specific recommendation DRI* Oxycodone Control Kit 100
Control Part Number N/A N/A 100254
Comment(s) User-defined reagent
45
Drugs of Abuse Testing (DAT)
Chemistry NameOxycodone
(300 cutoff)
Oxycodone
(semi-quantitative)
Phencyclidine
(25 cutoff)
Chemistry Abbreviation OXY OXY PCP+
Measurement Principle Homogeneous enzyme immunoassay Homogeneous enzyme immunoassay Emit ll* Plus
Reaction Type Rate Rate Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 17, 21 17, 21 15, 19
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 10.5 μL 10.5 μL 7 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 10.5 μL 10.5 μL 7 μL (AU480: 4.9 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 300 ng/mL 100/300 ng/mL 25 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 87, R2 = 87 R1 = 87, R2 = 87 R1 = 120, R2 = 50
AU480/AU680/AU2700/AU5400
R 1= 87, R2 = 87 R1 = 87, R2 = 87 R1 = 120, R2 = 50
(AU480: R1 = 84, R2 = 35)
Cartridge Part Number/Size
AU400/AU600/AU640 100248-(DRI) 70 mL kit (650 tests/kit)
100249-(DRI) 500 mL kit (5400 tests/kit)
100248-(DRI) 70 mL kit (650 tests/kit)
100249-(DRI) 500 mL kit (5400 tests/kit)
OSR9J229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 100248-(DRI) 70 mL ki (650 tests/kit)t
100249-(DRI) 500 mL kit (5400 tests/kit)
100248-(DRI) 70 mL kit (650 tests/kit)
100249-(DRI) 500 mL kit (5400 tests/kit)
OSR9J229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 30 days 30 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number DRI* Calibrator: 100251 DRI* Calibrators:100250, 100251,
100252, 100253, 1664/1388 –Neg. cal
9A569
Control Name DRI* Oxycodone Control Kit 300 DRI* Oxycodone Control Kit 100
DRI* Oxycodone Control Kit 300
No specific recommendation
Control Part Number 100255 DRI* Oxycodone Control Kit 100:
100254
DRI* Oxycodone Control Kit 300:
100255
N/A
Comment(s) User-defined reagent User-defined reagent
The negative calibrator 1664 has a
10 mL volume and the 1388 has a
25 mL volume
46
Drugs of Abuse Testing (DAT)
Chemistry NamePhencyclidine
(semi-quantitative)
Propoxyphene
(300 cutoff)
Propoxyphene
(semi-quantitative)
Chemistry Abbreviation PCP+ PPX+ PPX+
Measurement Principle Emit ll* Plus Emit ll* Plus Emit ll* Plus
Reaction Type Fixed Fixed Fixed
Primary Wavelength 340 nm 340 nm 340 nm
Measuring Points 15, 19 15, 19 15, 19
Sample Type Urine Urine Urine
Sample Size (AU400/AU600/AU640)
Serum/Plasma N/A N/A N/A
Urine 7 μL 7 μL 7 μL
CSF N/A N/A N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma N/A N/A N/A
Urine 7 μL (AU480: 4.9 μL) 7 μL (AU480: 4.9 μL) 7 μL (AU480: 4.9 μL)
CSF N/A N/A N/A
Cutoff Level
Serum/Plasma N/A N/A N/A
Urine 25 ng/mL 300 ng/mL 300 ng/mL
CSF N/A N/A N/A
Analytical Range (UDR)
Serum/Plasma N/A N/A N/A
Urine User defined User defined User defined
CSF N/A N/A N/A
Reagent Volume
AU400/AU600/AU640 R1 = 120, R2 = 50 R1 = 120, R2 = 50 R1= 120, R2 = 50
AU480/AU680/AU2700/AU5400
R1 = 120, R2 = 50
(AU480: R1 = 84, R2 = 35)
R1 = 120, R2 = 50
(AU480: R1 = 84, R2 = 35)
R1 = 120, R2 = 50
(AU480: R1 = 84, R2 = 35)
Cartridge Part Number/Size
AU400/AU600/AU640 OSR9J229 (2 x 200 tests) OSR9G229 (2 x 200 tests) OSR9G229 (2 x 200 tests)
AU480/AU680/AU2700/AU5400 OSR9J229 (2 x 200 tests) OSR9G229 (2 x 200 tests) OSR9G229 (2 x 200 tests)
Liquid or Lyophilized Liquid Liquid Liquid
On-Instrument Stability 60 days 60 days 60 days
Storage Temperature +2 to +8°C +2 to +8°C +2 to +8°C
Calibration Frequency 14 days 14 days 14 days
Reagent Blank Frequency 14 days 14 days 14 days
Compatible Anticoagulants N/A N/A N/A
Calibrator Part Number 9A549, 9A569, 9A589, 9A609 9A569 9A549, 9A569, 9A589
Control Name No specific recommendation No specific recommendation No specific recommendation
Control Part Number N/A N/A N/A
Comment(s)
47
Drugs of Abuse Testing (DAT)
Chemistry Name Tricyclics, Tox
Chemistry Abbreviation TRICY
Measurement Principle Emit* tox
Reaction Type Fixed
Primary Wavelength 340 nm
Measuring Points 12, 16
(AU480: 13, 15)
Sample Type Serum/Plasma
Sample Size (AU400/AU600/AU640)
Serum/Plasma 2.5 μL
Urine N/A
CSF N/A
Sample Size (AU480/AU680/
AU2700/AU5400)
Serum/Plasma 2.5 μL (AU480: 2 μL)
Urine N/A
CSF N/A
Cutoff Level
Serum/Plasma N/A
Urine N/A
CSF N/A
Analytical Range (UDR)
Serum/Plasma User defined
Urine N/A
CSF N/A
Reagent Volume
AU400/AU600/AU640 R1 = 75, R2 = 75
AU480/AU680/AU2700/AU5400 R1 = 75, R2 = 75
(AU480: R1 = 60, R2 = 60)
Cartridge Part Number/Size
AU400/AU600/AU640 7C209 (300 tests)
AU480/AU680/AU2700/AU5400 7C209 (300 tests)
Liquid or Lyophilized Lyophilized
On-Instrument Stability 35 days
Storage Temperature +2 to +8°C
Calibration Frequency 1 day
Reagent Blank Frequency 1 day
Compatible Anticoagulants Heparin
Oxalate
EDTA
Calibrator Part Number 7C219
Control Name No specific recommendation
Control Part Number N/A
Comment(s) User-defined reagent
49
Index
Acetaminophen (ACETA) ................................................................... 25
Alanine Aminotransferase (ALT) ..........................................................4
Albumin (ALB) .........................................................................................4
Alkaline Phosphatase (ALP) .................................................................4
Alpha-1-Acidglycoprotein (AAG) ...................................................... 15
Alpha-1-Antitrypsin (AAT) .................................................................. 15
Amylase (AMY)........................................................................................5
Amikacin (AMIK) .................................................................................. 25
Ammonia (AMMON) ........................................................................... 22
Amphetamines 300ng (AMPH+) ...................................................... 32
Amphetamines 500ng (AMPH+) ...................................................... 32
Amphetamines 1000ng (AMPH+) .................................................... 32
Amphetamines 300ng SQ (AMPH+) ............................................... 33
Amphetamines 500ng SQ (AMPH+) ............................................... 33
Amphetamines 1000ng SQ (AMPH+) ............................................. 33
Anti-Streptolysin O (ASO) ................................................................. 15
Apolipoprotein A1 (APO A1) ............................................................. 16
Apolipoprotein B (APO B) ................................................................. 16
Aspartate Aminotransferase (AST) ......................................................5
Barbiturate 200ng (BARB+) .............................................................. 34
Barbiturate 300ng (BARB+) .............................................................. 34
Barbiturate SQ (BARB+) ................................................................... 34
Barbiturate, Tox (TBARB) ................................................................... 35
Benzodiazepine 200ng (BENZ+) ..................................................... 35
Benzodiazepine 300ng (BENZ+) ..................................................... 35
Benzodiazepine SQ (BENZ+) .......................................................... 36
Benzodiazepine, Tox (TBENZ) .......................................................... 36
Beta-2 Microglobulin (B2M) ............................................................. 16
Bicarbonate (CO2) ................................................................................5
C-Reactive Protein (CRP) ................................................................. 18
C-Reactive Protein (CRPN) ............................................................. 18
C-Reactive Protein, High Sensitivity (CRPHS) .............................. 18
Caffeine (CAFF) .................................................................................. 26
Calcium Arsenazo (CALA) ....................................................................6
Calcium oCPC (CA) ..............................................................................6
Cannabinoid 20ng (THC) .................................................................. 36
Cannabinoid 50ng (THC) .................................................................. 37
Cannabinoid 100ng (THC) ................................................................ 37
Cannabinoid SQ (THC) ..................................................................... 37
Carbamazepine (CARB) .................................................................... 26
Ceruloplasmin (CER) ......................................................................... 17
Chloride (CL) ..........................................................................................6
Cholesterol (CHOL) ..............................................................................7
Cholinesterase (CHE) ........................................................................ 22
Cocaine Metabolite 150ng (COCA+) .............................................. 38
Cocaine Metabolite 300ng (COCA+) .............................................. 38
Cocaine Metabolite SQ (COCA+) ................................................... 38
Complement 3 (C3) ............................................................................ 17
Complement 4 (C4) ............................................................................ 17
Creatine Kinase MB (CKMB) ............................................................ 22
Creatinine (CRE) ....................................................................................7
Creatine Kinase (CK) .............................................................................7
Creatinine, Tox (CRTOX) .................................................................... 40
Digoxin (DIG) ....................................................................................... 27
Direct Bilirubin (DBIL) ...........................................................................8
Disopyramide (DISO) ......................................................................... 27
Ecstasy 300ng (XTC) ......................................................................... 39
Ecstasy 500ng (XTC) ......................................................................... 39
Ecstasy 300ng SQ (XTC) .................................................................. 40
Ecstasy 500ng SQ (XTC) .................................................................. 40
Ethosuximide (SUXI) ........................................................................... 27
Ethyl Alcohol (ETOH+) ....................................................................... 40
Ferritin (FERR) ..................................................................................... 19
Gamma-Glutamyltransferase (GGT) ...................................................8
Gentamicin (GENT) ............................................................................ 27
Glucose (GLU) .......................................................................................9
Haptoglobin (HAPT) ........................................................................... 19
HDL Cholesterol (HDL-C) ....................................................................9
Hemoglobin A1c (IFCC) (HBA1C) .................................................. 23
Immunoglobulin A (IGA) ..................................................................... 19
Immunoglobulin G (IGG) ................................................................... 20
Immunoglobulin M (IGM) ................................................................... 20
Iron (IRON) ..............................................................................................9
Lactate (LAC) ....................................................................................... 23
Lactate Dehydrogenase (IFCC) (LDH) ............................................ 10
LDL Cholesterol (LDL-C) .................................................................. 10
Lidocaine (LIDO) ................................................................................. 27
Lipase (LIP) .......................................................................................... 10
Lithium (LI) ............................................................................................ 23
LSD (LSD) ............................................................................................ 41
LSD SQ (LSD) ..................................................................................... 41
Magnesium (MG) ................................................................................ 11
Methadone 150ng (METH+) ............................................................. 41
Methadone 300ng (METH+) ............................................................. 42
Methadone SQ (METH+) ................................................................... 42
Methaqualone (METQ+) .................................................................... 42
Methaqualone SQ (METQ+) ............................................................. 43
Methotrexate (MTRX) .......................................................................... 28
Microalbumin (MALB)......................................................................... 20
N-Acetylprocainamide (NAPA) .......................................................... 28
Opiates 300ng (OPIA+) ..................................................................... 43
Opiates 2000ng (OPIA+) .................................................................. 43
Opiates 300ng SQ (OPIA+).............................................................. 44
Opiates 2000ng SQ (OPIA+) ........................................................... 44
Oxycodone 100ng (OXY) ................................................................... 44
Oxycodone 300ng (OXY) .................................................................. 45
Oxycodone SQ (OXY) ........................................................................ 45
Phencyclidine (PCP+) ........................................................................ 45
Phencyclidine SQ (PCP+) ................................................................. 46
Phenobarbital (PBARB) ..................................................................... 28
Phenytoin (PHENY) ............................................................................ 29
Phosphorus, Inorganic (PHOS) ....................................................... 11
Potassium (K) ....................................................................................... 11
Prealbumin (PALB).............................................................................. 21
Primidone (PRIM) ................................................................................ 29
Procainamide (PROC) ....................................................................... 29
Propoxyphene (PPX+) ........................................................................ 46
Propoxyphene SQ (PPX+) ................................................................. 46
Quinidine (QUIN) ................................................................................ 30
Rheumatoid Factor (RF) ..................................................................... 21
Salicylic Acid (SALI) ........................................................................... 30
Sodium (NA)......................................................................................... 12
T-Uptake (TUP) .................................................................................... 24
Theophylline (THEO) .......................................................................... 30
Thyroxine (T4) ...................................................................................... 24
Tobramycin (TOB) ............................................................................... 31
Total Bilirubin (TBIL) ........................................................................... 12
Total Protein (TP) ................................................................................. 12
Transferrin (TRF) ................................................................................. 21
Triglyceride (TRIG) .............................................................................. 13
Tricyclics, Tox (TRICY)........................................................................ 45
Unsaturated Iron Binding Capacity (UIBC) .................................... 13
Urea Nitrogen (BUN) .......................................................................... 13
Uric Acid (UA) ...................................................................................... 14
Urinary/CSF Protein (UCSFP) .......................................................... 14
Valproic Acid (VPA) ............................................................................. 31
Vancomycin (VANC) ............................................................................ 31
Notes
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
Notes
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
*All trademarks are the property of their respective owners.
Beckman Coulter, the stylized logo, AU, AU400, AU480, AU600, AU640, AU680, AU2700, AU5400 are
registered trademarks of Beckman Coulter, Inc.
Laboratories around the world rely on Beckman Coulter’s promise of
quality, integrity and innovation. Our total laboratory solutions deliver
accurate information for medical research breakthroughs, clinical trials,
laboratory diagnostics and point-of-care testing. A partnership with
Beckman Coulter extends far beyond our products. With extensive
expertise in analyzing laboratory test processes, we collaborate with
you to understand your requirements and create flexible solutions that
meet your evolving needs.
We’re better together. And together, we make a positive impact in
people’s lives.
For Beckman Coulter’s worldwide offi ce locations and phone numbers, please visit “Contact Us” at www.beckmancoulter.com
B2011-12240 © 2011 Beckman Coulter, Inc. PRINTED IN U.S.A.
Printed with soy ink
Space for
FSC Logo
Top Related